<!DOCTYPE html><html lang="en" class="bg-surface-base antialiased"><head><meta charSet="utf-8"/><meta name="viewport" content="width=device-width, initial-scale=1, interactive-widget=resizes-content"/><link rel="stylesheet" href="/_next/static/css/62c4caba71dfda84.css" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/eb3d87f98fe1565f.css" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/1b5e561215938d4d.css" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/0227d069a630d414.css" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/f87fff2ab93d05a7.css" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx" data-precedence="next"/><link rel="preload" as="script" fetchPriority="low" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx" href="/_next/static/chunks/webpack-e121ed42680f327e.js"/><script src="/_next/static/chunks/78a669d9-e7993486b22c4915.js" async="" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx"></script><script src="/_next/static/chunks/40c4a5a7-abdabb07419d1cfc.js" async="" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx"></script><script src="/_next/static/chunks/2230-f7c87dc9fa57c408.js" async="" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx"></script><script src="/_next/static/chunks/main-app-536d4b8fca62396a.js" async="" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx"></script><script src="/_next/static/chunks/63f0ec43-8ee6a76d70472249.js" async="" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx"></script><script src="/_next/static/chunks/7670-7326298c9856172b.js" async="" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx"></script><script src="/_next/static/chunks/282-691fffb366e24ca5.js" async="" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx"></script><script src="/_next/static/chunks/7515-336759ef5dad2b52.js" async="" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx"></script><script src="/_next/static/chunks/927-34e2a6da3e15e26b.js" async="" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx"></script><script src="/_next/static/chunks/5855-243eeca8f0e4cabd.js" async="" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx"></script><script src="/_next/static/chunks/4393-1c8dff25ec904469.js" async="" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx"></script><script src="/_next/static/chunks/2225-454cf9f44775e7ce.js" async="" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx"></script><script src="/_next/static/chunks/7618-43536a8fb0dd3bfe.js" async="" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js" async="" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx"></script><script src="/_next/static/chunks/7720-3a1e7e411adba2d3.js" async="" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx"></script><script src="/_next/static/chunks/7086-1f1c4891d766e04f.js" async="" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/not-found-69a3edc7db5749d6.js" async="" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx"></script><script src="/_next/static/chunks/app/global-error-4d07d20223cd4b4c.js" async="" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx"></script><script src="/_next/static/chunks/8208b75a-a48e5a4507a0de91.js" async="" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx"></script><script src="/_next/static/chunks/5497-ab85ef3ea59dd353.js" async="" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx"></script><script src="/_next/static/chunks/6281-c6e84786dade3614.js" async="" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx"></script><script src="/_next/static/chunks/2660-d983a7f287e89f18.js" async="" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx"></script><script src="/_next/static/chunks/5002-9735c25beda556ba.js" async="" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx"></script><script src="/_next/static/chunks/3655-6717081f7512305a.js" async="" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx"></script><script src="/_next/static/chunks/8945-e4e3cf487f5e27c7.js" async="" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx"></script><script src="/_next/static/chunks/9214-a10614844a67ba31.js" async="" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx"></script><script src="/_next/static/chunks/4789-2080f6497f78b5b6.js" async="" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx"></script><script src="/_next/static/chunks/app/layout-226f2bd71acf9f9e.js" async="" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx"></script><script src="/_next/static/chunks/24cf1b50-159cca90b09285e0.js" async="" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx"></script><script src="/_next/static/chunks/9ffa21ba-c069766d809bd4c7.js" async="" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx"></script><script src="/_next/static/chunks/600-9a9fcafaaa6c1c4c.js" async="" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx"></script><script src="/_next/static/chunks/5448-2a3cfd853d899c9a.js" async="" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx"></script><script src="/_next/static/chunks/8-8ca70ca619d8e099.js" async="" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js" async="" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx"></script><script src="/_next/static/chunks/app/error-4a29e9399afba038.js" async="" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx"></script><script src="/_next/static/chunks/app/not-found-dd95690acf732f18.js" async="" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx"></script><meta name="next-size-adjust" content=""/><title>Grokipedia</title><meta name="description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><link rel="icon" type="image/x-icon" href="/favicon.ico" sizes="48x48"/><link rel="icon" href="/images/icon-dark.png" media="(prefers-color-scheme: light)" type="image/png"/><link rel="icon" href="/images/icon-light.png" media="(prefers-color-scheme: dark)" type="image/png"/><link rel="apple-touch-icon" href="/icon-192x192.png"/><link rel="manifest" href="/manifest.webmanifest"/><meta name="robots" content="index, follow"/><meta name="googlebot" content="index, follow, max-snippet:-1"/><meta property="og:title" content="Grokipedia"/><meta property="og:description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><meta property="og:url" content="https://grokipedia.com"/><meta property="og:site_name" content="Grokipedia"/><meta property="og:locale" content="en_US"/><meta property="og:type" content="website"/><meta property="og:image" content="https://grokipedia.com/icon-512x512.png"/><meta property="og:image:width" content="512"/><meta property="og:image:height" content="512"/><meta property="og:image:alt" content="Grokipedia"/><meta name="twitter:card" content="summary"/><meta name="twitter:creator" content="@Grokipedia"/><meta name="twitter:title" content="Grokipedia"/><meta name="twitter:description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><meta name="twitter:image" content="https://grokipedia.com/icon-512x512.png"/><title>List of countries by prevalence of opiates use</title><meta name="description" content="The list of countries by prevalence of opiates use ranks nations based on the estimated annual prevalence rate of opiate consumption—encompassing substances like heroin, opium, and morphine—among the population aged 15–64, as compiled from national surveys, treatment records, and indirect indicators by the United Nations Office on Drugs and Crime (UNODC). These figures reflect past-year use and serve as a metric for assessing the scale of illicit opiate involvement relative to population size,..."/><meta name="author" content="system"/><link rel="manifest" href="/manifest.webmanifest"/><meta name="robots" content="index, follow"/><meta name="googlebot" content="index, follow, max-snippet:-1"/><link rel="canonical" href="https://grokipedia.com/page/List_of_countries_by_prevalence_of_opiates_use"/><meta property="og:title" content="List of countries by prevalence of opiates use"/><meta property="og:description" content="The list of countries by prevalence of opiates use ranks nations based on the estimated annual prevalence rate of opiate consumption—encompassing substances like heroin, opium, and morphine—among the population aged 15–64, as compiled from national surveys, treatment records, and indirect indicators by the United Nations Office on Drugs and Crime (UNODC). These figures reflect past-year use and serve as a metric for assessing the scale of illicit opiate involvement relative to population size,..."/><meta property="og:url" content="https://grokipedia.com/page/List_of_countries_by_prevalence_of_opiates_use"/><meta property="og:site_name" content="Grokipedia"/><meta property="og:locale" content="en"/><meta property="og:image" content="https://grokipedia.com/icon-512x512.png"/><meta property="og:image:width" content="512"/><meta property="og:image:height" content="512"/><meta property="og:image:alt" content="List of countries by prevalence of opiates use"/><meta property="og:type" content="article"/><meta property="article:modified_time" content="1970-01-21T09:19:42.691Z"/><meta name="twitter:card" content="summary"/><meta name="twitter:creator" content="@Grokipedia"/><meta name="twitter:title" content="List of countries by prevalence of opiates use"/><meta name="twitter:description" content="The list of countries by prevalence of opiates use ranks nations based on the estimated annual prevalence rate of opiate consumption—encompassing substances like heroin, opium, and morphine—among the population aged 15–64, as compiled from national surveys, treatment records, and indirect indicators by the United Nations Office on Drugs and Crime (UNODC). These figures reflect past-year use and serve as a metric for assessing the scale of illicit opiate involvement relative to population size,..."/><meta name="twitter:image" content="https://grokipedia.com/icon-512x512.png"/><link rel="icon" href="/favicon.ico" type="image/x-icon" sizes="16x16"/><meta name="sentry-trace" content="dab62d0e8d5c6def68c3767e316f21a9-f2d87037683e2291-1"/><meta name="baggage" content="sentry-environment=production,sentry-public_key=5f2258f71198ee26a355127af230c3a6,sentry-trace_id=dab62d0e8d5c6def68c3767e316f21a9,sentry-org_id=4508179396558848,sentry-transaction=GET%20%2Fpage%2F%5Bslug%5D,sentry-sampled=true,sentry-sample_rand=0.6759725756145576,sentry-sample_rate=1"/><script src="/_next/static/chunks/polyfills-42372ed130431b0a.js" noModule="" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx"></script></head><body class="flex h-[100svh] w-full flex-col __variable_13c637 __variable_8a0ba0 __variable_779740 __variable_2484fd __variable_525cc3 __variable_13486b"><div hidden=""><!--$--><!--/$--></div><script nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx">((a,b,c,d,e,f,g,h)=>{let i=document.documentElement,j=["light","dark"];function k(b){var c;(Array.isArray(a)?a:[a]).forEach(a=>{let c="class"===a,d=c&&f?e.map(a=>f[a]||a):e;c?(i.classList.remove(...d),i.classList.add(f&&f[b]?f[b]:b)):i.setAttribute(a,b)}),c=b,h&&j.includes(c)&&(i.style.colorScheme=c)}if(d)k(d);else try{let a=localStorage.getItem(b)||c,d=g&&"system"===a?window.matchMedia("(prefers-color-scheme: dark)").matches?"dark":"light":a;k(d)}catch(a){}})("class","theme","dark",null,["light","dark"],null,true,true)</script><header class="h-16 bg-surface-base fixed top-0 z-50 w-full"><div class="hidden h-full grid-cols-[1fr_3fr_1fr] items-center gap-4 !py-0 md:grid max-w-full py-6 px-4 w-full mx-auto"><div class="-ml-2 justify-self-start"><a class="cursor-pointer" href="/"><svg width="200" height="auto" viewBox="0 0 955 225" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M99.6937 159.214C90.008 159.214 81.5652 157.414 74.3652 153.814C67.1652 150.214 61.5509 144.986 57.5223 138.129C53.5794 131.271 51.608 123.043 51.608 113.443C51.608 103.843 53.5794 95.4857 57.5223 88.3714C61.5509 81.2572 67.1652 75.7286 74.3652 71.7857C81.6509 67.8429 90.1794 65.8714 99.9509 65.8714C103.208 65.8714 106.679 66.1286 110.365 66.6429C114.051 67.0714 117.222 67.6714 119.879 68.4429C121.508 68.8714 123.008 69.2572 124.379 69.6C125.751 69.9429 127.122 70.1143 128.494 70.1143C129.522 70.1143 130.551 69.9857 131.579 69.7286C131.751 73.5 131.922 77.4 132.094 81.4286C132.265 85.4572 132.522 89.6572 132.865 94.0286C131.065 94.2857 129.565 94.3714 128.365 94.2857C126.651 86.4 123.522 80.5714 118.979 76.8C114.437 72.9429 108.394 71.0143 100.851 71.0143C94.8509 71.0143 89.708 72.1286 85.4223 74.3572C81.2223 76.5 77.7937 79.4572 75.1366 83.2286C72.5652 87 70.6794 91.3714 69.4794 96.3429C68.2794 101.229 67.6794 106.457 67.6794 112.029C67.6794 120.171 68.9223 127.371 71.408 133.629C73.8937 139.886 77.6652 144.814 82.7223 148.414C87.8652 151.929 94.2937 153.686 102.008 153.686C104.408 153.686 107.065 153.471 109.979 153.043C112.894 152.529 115.679 151.757 118.337 150.729V134.529C118.337 131.871 118.208 129.814 117.951 128.357C117.779 126.814 117.222 125.7 116.279 125.014C115.422 124.329 114.008 123.857 112.037 123.6C110.151 123.257 107.537 122.957 104.194 122.7C103.937 121.329 103.937 119.957 104.194 118.586C105.994 118.586 108.179 118.629 110.751 118.714C113.322 118.714 115.894 118.757 118.465 118.843C121.122 118.843 123.308 118.843 125.022 118.843C127.679 118.843 130.722 118.8 134.151 118.714C137.665 118.629 140.665 118.586 143.151 118.586C143.322 119.871 143.322 121.2 143.151 122.571C139.637 123 137.108 123.429 135.565 123.857C134.022 124.286 133.079 125.143 132.737 126.429C132.394 127.714 132.222 129.9 132.222 132.986V137.1C132.222 141.129 132.308 144.514 132.479 147.257C132.737 150 132.951 151.971 133.122 153.171C121.208 157.2 110.065 159.214 99.6937 159.214ZM148.19 157.414C147.933 156.043 147.933 154.714 148.19 153.429C151.105 153.257 153.248 153 154.619 152.657C155.99 152.229 156.89 151.371 157.319 150.086C157.748 148.8 157.962 146.743 157.962 143.914V115.114C157.962 111.771 157.79 109.286 157.448 107.657C157.19 106.029 156.376 104.914 155.005 104.314C153.719 103.629 151.49 103.071 148.319 102.643C148.062 101.443 148.062 100.329 148.319 99.3C151.748 98.6143 155.09 97.8429 158.348 96.9857C161.605 96.0429 165.033 94.8429 168.633 93.3857L170.819 94.1572V105.471C176.819 97.8429 182.948 94.0286 189.205 94.0286C192.205 94.0286 194.433 94.8429 195.89 96.4714C197.348 98.0143 198.076 99.7714 198.076 101.743C198.076 104.057 197.305 105.857 195.762 107.143C194.219 108.343 192.462 108.943 190.49 108.943C188.862 108.943 187.233 108.514 185.605 107.657C184.062 106.8 182.905 105.471 182.133 103.671C179.219 103.671 176.605 104.829 174.29 107.143C172.062 109.371 170.948 111.986 170.948 114.986V142.629C170.948 145.971 171.119 148.371 171.462 149.829C171.89 151.286 172.919 152.229 174.548 152.657C176.262 153 179.005 153.257 182.776 153.429C182.948 154.629 182.948 155.957 182.776 157.414C179.862 157.414 176.862 157.371 173.776 157.286C170.69 157.2 167.519 157.157 164.262 157.157C161.09 157.157 158.262 157.2 155.776 157.286C153.376 157.371 150.848 157.414 148.19 157.414ZM229.285 158.829C223.028 158.829 217.542 157.5 212.828 154.843C208.199 152.1 204.599 148.371 202.028 143.657C199.457 138.857 198.171 133.371 198.171 127.2C198.171 120.514 199.499 114.686 202.157 109.714C204.899 104.743 208.714 100.886 213.599 98.1429C218.485 95.4 224.099 94.0286 230.442 94.0286C236.699 94.0286 242.142 95.4 246.771 98.1429C251.399 100.886 254.999 104.657 257.571 109.457C260.142 114.257 261.428 119.7 261.428 125.786C261.428 132.043 260.057 137.7 257.314 142.757C254.657 147.729 250.928 151.671 246.128 154.586C241.328 157.414 235.714 158.829 229.285 158.829ZM212.699 125.657C212.699 134.4 214.114 141.343 216.942 146.486C219.857 151.543 224.185 154.071 229.928 154.071C235.414 154.071 239.614 151.671 242.528 146.871C245.442 141.986 246.899 135.471 246.899 127.329C246.899 118.671 245.442 111.771 242.528 106.629C239.614 101.486 235.371 98.9143 229.799 98.9143C224.314 98.9143 220.071 101.271 217.071 105.986C214.157 110.7 212.699 117.257 212.699 125.657ZM267.394 157.414C267.308 157.071 267.265 156.729 267.265 156.386C267.265 156.043 267.265 155.7 267.265 155.357C267.265 155.014 267.265 154.714 267.265 154.457C267.265 154.114 267.308 153.771 267.394 153.429C270.308 153.257 272.451 153 273.822 152.657C275.194 152.229 276.094 151.371 276.522 150.086C276.951 148.8 277.165 146.743 277.165 143.914V79.5C277.165 76.8429 276.908 74.8714 276.394 73.5857C275.965 72.2143 274.979 71.2714 273.437 70.7572C271.979 70.1572 269.751 69.7286 266.751 69.4714C266.665 69.1286 266.622 68.8286 266.622 68.5714C266.622 68.3143 266.622 68.0572 266.622 67.8C266.622 67.4572 266.622 67.1572 266.622 66.9C266.622 66.6429 266.665 66.3429 266.751 66C270.179 65.5714 273.694 64.9286 277.294 64.0714C280.894 63.1286 284.579 61.8429 288.351 60.2143L290.537 60.9857C290.451 62.8714 290.365 65.0143 290.279 67.4143C290.279 69.8143 290.279 72.4286 290.279 75.2572V122.957C291.308 122.957 292.165 122.786 292.851 122.443C293.537 122.1 294.094 121.757 294.522 121.414C294.694 121.243 295.037 120.943 295.551 120.514C296.065 120 296.965 119.1 298.251 117.814C299.537 116.529 301.379 114.6 303.779 112.029C306.008 109.543 307.765 107.614 309.051 106.243C310.422 104.786 311.108 103.586 311.108 102.643C311.108 101.957 310.508 101.4 309.308 100.971C308.194 100.457 306.651 100.157 304.679 100.071C304.594 99.7286 304.551 99.3857 304.551 99.0429C304.551 98.7 304.551 98.3572 304.551 98.0143C304.551 97.6714 304.551 97.3286 304.551 96.9857C304.551 96.6429 304.594 96.3 304.679 95.9572C306.394 95.9572 308.537 96 311.108 96.0857C313.765 96.1714 316.122 96.2143 318.179 96.2143C319.208 96.2143 320.665 96.2143 322.551 96.2143C324.522 96.1286 326.494 96.0857 328.465 96.0857C330.437 96.0857 331.894 96.0857 332.837 96.0857C332.922 96.4286 332.965 96.7714 332.965 97.1143C333.051 97.4572 333.094 97.8 333.094 98.1429C333.094 98.4857 333.051 98.8286 332.965 99.1714C332.965 99.4286 332.922 99.7286 332.837 100.071C328.379 100.157 324.608 101.271 321.522 103.414C318.437 105.471 315.479 107.914 312.651 110.743L303.394 120L321.137 143.4C323.022 145.886 324.565 147.857 325.765 149.314C327.051 150.686 328.422 151.671 329.879 152.271C331.337 152.871 333.351 153.257 335.922 153.429C336.094 154.629 336.094 155.957 335.922 157.414C334.808 157.414 333.137 157.371 330.908 157.286C328.765 157.2 325.379 157.157 320.751 157.157C320.065 157.157 319.037 157.157 317.665 157.157C316.294 157.157 315.008 157.243 313.808 157.414C313.808 156.471 313.294 155.186 312.265 153.557C311.237 151.843 310.422 150.6 309.822 149.829C309.565 149.4 308.922 148.5 307.894 147.129C306.865 145.671 305.622 144 304.165 142.114C302.794 140.143 301.379 138.171 299.922 136.2C298.465 134.143 297.137 132.343 295.937 130.8C294.994 129.514 294.094 128.529 293.237 127.843C292.465 127.071 291.479 126.686 290.279 126.686V142.629C290.279 145.971 290.408 148.371 290.665 149.829C291.008 151.286 291.737 152.229 292.851 152.657C294.051 153 295.851 153.257 298.251 153.429C298.422 154.714 298.422 156.043 298.251 157.414C296.022 157.414 293.665 157.371 291.179 157.286C288.779 157.2 286.165 157.157 283.337 157.157C280.594 157.157 277.894 157.2 275.237 157.286C272.579 157.371 269.965 157.414 267.394 157.414ZM369.34 157.414C366.94 157.414 364.454 157.371 361.883 157.286C359.311 157.2 356.526 157.157 353.526 157.157C350.783 157.157 347.997 157.2 345.169 157.286C342.426 157.371 339.769 157.414 337.197 157.414C336.94 156.043 336.94 154.714 337.197 153.429C340.111 153.257 342.254 153 343.626 152.657C344.997 152.229 345.897 151.371 346.326 150.086C346.754 148.8 346.969 146.743 346.969 143.914V115.114C346.969 111.771 346.84 109.286 346.583 107.657C346.326 106.029 345.511 104.914 344.14 104.314C342.854 103.629 340.583 103.071 337.326 102.643C337.069 101.443 337.069 100.329 337.326 99.3C341.097 98.6143 344.697 97.7572 348.126 96.7286C351.554 95.7 354.854 94.5857 358.026 93.3857L360.211 94.1572C360.126 96.8143 360.04 99.3 359.954 101.614C359.954 103.929 359.954 106.114 359.954 108.171V142.629C359.954 145.971 360.126 148.371 360.469 149.829C360.897 151.286 361.754 152.229 363.04 152.657C364.411 153 366.511 153.257 369.34 153.429C369.597 154.714 369.597 156.043 369.34 157.414ZM343.626 71.5286C343.626 69.0429 344.483 66.9429 346.197 65.2286C347.997 63.5143 350.14 62.6572 352.626 62.6572C355.026 62.6572 357.083 63.5143 358.797 65.2286C360.597 66.9429 361.497 69 361.497 71.4C361.497 73.6286 360.64 75.6857 358.926 77.5715C357.211 79.3714 355.026 80.2714 352.369 80.2714C349.969 80.2714 347.911 79.4143 346.197 77.7C344.483 75.9857 343.626 73.9286 343.626 71.5286ZM372.678 188.914C372.592 187.543 372.592 186.214 372.678 184.929C375.678 184.757 377.864 184.457 379.235 184.029C380.607 183.6 381.464 182.743 381.807 181.457C382.235 180.257 382.45 178.286 382.45 175.543V115.114C382.45 111.771 382.278 109.286 381.935 107.657C381.678 106.029 380.864 104.914 379.492 104.314C378.207 103.629 375.978 103.071 372.807 102.643C372.635 101.443 372.635 100.329 372.807 99.3C376.321 98.6143 379.75 97.8 383.092 96.8572C386.435 95.9143 389.907 94.7572 393.507 93.3857L395.307 94.2857C395.221 96.4286 395.178 98.2714 395.178 99.8143C395.178 101.271 395.178 102.686 395.178 104.057C398.521 100.543 401.821 98.0143 405.078 96.4714C408.335 94.8429 411.807 94.0286 415.492 94.0286C420.892 94.0286 425.435 95.4429 429.121 98.2714C432.892 101.1 435.764 104.786 437.735 109.329C439.707 113.871 440.692 118.8 440.692 124.114C440.692 130.371 439.321 136.157 436.578 141.471C433.921 146.7 430.192 150.9 425.392 154.071C420.592 157.243 415.021 158.829 408.678 158.829C406.192 158.829 403.835 158.614 401.607 158.186C399.378 157.843 397.278 157.329 395.307 156.643V174C395.307 177.343 395.564 179.743 396.078 181.2C396.592 182.657 397.707 183.557 399.421 183.9C401.135 184.329 403.835 184.629 407.521 184.8C407.607 186.171 407.607 187.543 407.521 188.914C404.607 188.914 401.65 188.871 398.65 188.786C395.735 188.7 392.521 188.657 389.007 188.657C385.664 188.657 382.792 188.7 380.392 188.786C377.992 188.871 375.421 188.914 372.678 188.914ZM395.178 146.1C398.864 151.414 403.75 154.071 409.835 154.071C414.121 154.071 417.507 152.871 419.992 150.471C422.564 148.071 424.407 144.943 425.521 141.086C426.721 137.229 427.321 133.157 427.321 128.871C427.321 124.586 426.764 120.386 425.65 116.271C424.535 112.157 422.692 108.771 420.121 106.114C417.635 103.371 414.207 102 409.835 102C404.607 102 399.721 104.529 395.178 109.586V146.1ZM477.335 158.829C471.25 158.829 466.107 157.414 461.907 154.586C457.707 151.757 454.493 147.986 452.264 143.271C450.121 138.471 449.05 133.2 449.05 127.457C449.05 121.543 450.164 116.057 452.393 111C454.707 105.943 458.05 101.871 462.421 98.7857C466.793 95.6143 472.107 94.0286 478.364 94.0286C485.907 94.0286 491.778 96.3 495.978 100.843C500.264 105.3 502.407 111.086 502.407 118.2C502.407 119.057 502.364 119.829 502.278 120.514C502.278 121.114 502.235 121.629 502.15 122.057L461.65 121.671C461.65 122.014 461.65 122.314 461.65 122.571C461.65 130.971 463.578 137.571 467.435 142.371C471.293 147.171 476.693 149.571 483.635 149.571C489.464 149.571 495.207 147.686 500.864 143.914C501.721 144.943 502.364 145.929 502.793 146.871C495.507 154.843 487.021 158.829 477.335 158.829ZM462.035 116.914L488.65 116.4C488.735 116.229 488.778 116.014 488.778 115.757C488.778 115.414 488.778 115.2 488.778 115.114C488.778 110.486 487.75 106.629 485.693 103.543C483.721 100.457 480.764 98.9143 476.821 98.9143C473.135 98.9143 469.921 100.414 467.178 103.414C464.435 106.414 462.721 110.914 462.035 116.914ZM559.644 158.957L557.587 158.057L557.073 149.186C554.073 152.443 550.987 154.886 547.816 156.514C544.73 158.057 541.302 158.829 537.53 158.829C532.216 158.829 527.544 157.414 523.516 154.586C519.573 151.671 516.53 147.9 514.387 143.271C512.244 138.643 511.173 133.629 511.173 128.229C511.173 121.971 512.502 116.271 515.159 111.129C517.902 105.986 521.716 101.871 526.602 98.7857C531.573 95.6143 537.359 94.0286 543.959 94.0286C545.93 94.0286 547.987 94.2 550.13 94.5429C552.273 94.8 554.502 95.2714 556.816 95.9572V79.5C556.816 76.8429 556.559 74.8714 556.044 73.5857C555.53 72.2143 554.502 71.2714 552.959 70.7572C551.502 70.1572 549.273 69.7286 546.273 69.4714C546.016 68.3572 546.016 67.2 546.273 66C549.702 65.5714 553.216 64.9286 556.816 64.0714C560.416 63.1286 564.102 61.8429 567.873 60.2143L570.059 60.9857C569.973 62.8714 569.887 65.0143 569.802 67.4143C569.802 69.8143 569.802 72.4286 569.802 75.2572V139.029C569.802 142.286 569.93 144.729 570.187 146.357C570.445 147.986 571.216 149.143 572.502 149.829C573.787 150.429 575.973 150.986 579.059 151.5C579.316 152.614 579.316 153.771 579.059 154.971C575.63 155.486 572.287 156.043 569.03 156.643C565.773 157.243 562.644 158.014 559.644 158.957ZM556.944 106.886C553.259 101.829 548.416 99.3 542.416 99.3C536.502 99.3 532.044 101.486 529.044 105.857C526.044 110.143 524.544 116.1 524.544 123.729C524.544 128.186 525.144 132.471 526.344 136.586C527.544 140.7 529.516 144.086 532.259 146.743C535.002 149.4 538.644 150.729 543.187 150.729C548.93 150.729 553.516 148.243 556.944 143.271V106.886ZM615.699 157.414C613.299 157.414 610.813 157.371 608.242 157.286C605.67 157.2 602.885 157.157 599.885 157.157C597.142 157.157 594.356 157.2 591.527 157.286C588.785 157.371 586.127 157.414 583.556 157.414C583.299 156.043 583.299 154.714 583.556 153.429C586.47 153.257 588.613 153 589.985 152.657C591.356 152.229 592.256 151.371 592.685 150.086C593.113 148.8 593.327 146.743 593.327 143.914V115.114C593.327 111.771 593.199 109.286 592.942 107.657C592.685 106.029 591.87 104.914 590.499 104.314C589.213 103.629 586.942 103.071 583.685 102.643C583.427 101.443 583.427 100.329 583.685 99.3C587.456 98.6143 591.056 97.7572 594.485 96.7286C597.913 95.7 601.213 94.5857 604.385 93.3857L606.57 94.1572C606.485 96.8143 606.399 99.3 606.313 101.614C606.313 103.929 606.313 106.114 606.313 108.171V142.629C606.313 145.971 606.485 148.371 606.827 149.829C607.256 151.286 608.113 152.229 609.399 152.657C610.77 153 612.87 153.257 615.699 153.429C615.956 154.714 615.956 156.043 615.699 157.414ZM589.985 71.5286C589.985 69.0429 590.842 66.9429 592.556 65.2286C594.356 63.5143 596.499 62.6572 598.985 62.6572C601.385 62.6572 603.442 63.5143 605.156 65.2286C606.956 66.9429 607.856 69 607.856 71.4C607.856 73.6286 606.999 75.6857 605.285 77.5715C603.57 79.3714 601.385 80.2714 598.727 80.2714C596.327 80.2714 594.27 79.4143 592.556 77.7C590.842 75.9857 589.985 73.9286 589.985 71.5286ZM665.837 158.571C660.18 158.571 656.623 155.743 655.165 150.086C649.08 155.914 642.865 158.829 636.523 158.829C632.151 158.829 628.423 157.543 625.337 154.971C622.337 152.314 620.837 148.671 620.837 144.043C620.837 132.729 632.365 125.614 655.423 122.7C655.423 120.643 655.423 118.543 655.423 116.4C655.508 114.257 655.551 111.986 655.551 109.586C655.551 106.586 654.437 104.271 652.208 102.643C650.065 100.929 647.451 100.071 644.365 100.071C642.137 100.071 640.251 100.414 638.708 101.1C638.708 103.071 638.28 105.086 637.423 107.143C636.565 109.2 635.365 110.957 633.823 112.414C632.365 113.786 630.565 114.471 628.423 114.471C626.537 114.471 625.037 113.957 623.923 112.929C622.894 111.814 622.38 110.486 622.38 108.943C622.38 106.886 623.323 104.957 625.208 103.157C627.18 101.271 629.665 99.6857 632.665 98.4C635.665 97.0286 638.794 95.9572 642.051 95.1857C645.308 94.4143 648.223 94.0286 650.794 94.0286C653.965 94.0286 656.88 94.6286 659.537 95.8286C662.28 96.9429 664.465 98.6572 666.094 100.971C667.808 103.2 668.665 105.986 668.665 109.329C668.665 111.386 668.623 114.086 668.537 117.429C668.451 120.686 668.365 124.2 668.28 127.971C668.28 131.657 668.237 135.171 668.151 138.514C668.065 141.857 668.023 144.557 668.023 146.614C668.023 149.357 669.223 150.729 671.623 150.729C673.165 150.729 675.523 150.214 678.694 149.186C679.037 149.614 679.251 150.086 679.337 150.6C679.508 151.114 679.637 151.586 679.723 152.014C677.58 154.329 675.308 156 672.908 157.029C670.594 158.057 668.237 158.571 665.837 158.571ZM655.165 146.614L655.423 127.329C647.537 128.357 642.094 130.029 639.094 132.343C636.18 134.657 634.723 137.614 634.723 141.214C634.723 144.214 635.494 146.529 637.037 148.157C638.665 149.7 640.68 150.471 643.08 150.471C644.623 150.471 646.337 150.129 648.223 149.443C650.194 148.757 652.508 147.814 655.165 146.614Z" fill="currentColor"></path><rect x="715" y="65" width="195" height="105" rx="52.5" fill="currentColor" fill-opacity="0.05"></rect><path d="M767.529 142.875L754.049 107.938H762.552L769.309 127.582C769.705 128.812 770.078 130.032 770.43 131.24C770.781 132.449 771.078 133.559 771.32 134.569H771.616C771.858 133.559 772.144 132.449 772.473 131.24C772.825 130.032 773.198 128.812 773.594 127.582L780.186 107.938H788.689L775.472 142.875H767.529ZM810.856 143.633C806.901 143.633 803.528 142.71 800.737 140.865C797.969 138.997 795.871 136.305 794.442 132.79C793.014 129.252 792.3 124.989 792.3 120.001V118.255C792.3 113.245 793.014 108.982 794.442 105.467C795.871 101.929 797.969 99.2373 800.737 97.3916C803.528 95.5239 806.901 94.5901 810.856 94.5901C814.789 94.5901 818.129 95.5129 820.875 97.3586C823.644 99.2043 825.731 101.907 827.138 105.467C828.566 109.004 829.28 113.267 829.28 118.255V120.001C829.28 124.989 828.577 129.252 827.171 132.79C825.764 136.327 823.677 139.019 820.908 140.865C818.162 142.71 814.811 143.633 810.856 143.633ZM810.889 136.382C813.064 136.382 814.877 135.789 816.327 134.602C817.799 133.416 818.898 131.658 819.623 129.329C820.348 126.978 820.711 124.066 820.711 120.595V117.694C820.711 114.223 820.337 111.311 819.59 108.96C818.865 106.609 817.777 104.84 816.327 103.654C814.877 102.445 813.064 101.841 810.889 101.841C808.714 101.841 806.879 102.434 805.385 103.621C803.912 104.785 802.792 106.554 802.023 108.927C801.276 111.278 800.902 114.201 800.902 117.694V120.595C800.902 124.044 801.287 126.945 802.056 129.296C802.825 131.647 803.945 133.416 805.418 134.602C806.89 135.789 808.714 136.382 810.889 136.382ZM838.988 143.205C838 143.205 837.099 142.985 836.286 142.545C835.495 142.106 834.879 141.491 834.44 140.7C834.001 139.909 833.781 139.019 833.781 138.03C833.781 137.019 834.001 136.118 834.44 135.327C834.879 134.536 835.495 133.921 836.286 133.482C837.099 133.042 838 132.823 838.988 132.823C839.977 132.823 840.867 133.042 841.658 133.482C842.449 133.921 843.064 134.536 843.504 135.327C843.943 136.118 844.163 137.019 844.163 138.03C844.163 139.019 843.943 139.909 843.504 140.7C843.064 141.491 842.449 142.106 841.658 142.545C840.867 142.985 839.977 143.205 838.988 143.205ZM857.365 142.875V104.511L846.39 111.663V103.357L858.453 95.3481H865.802V142.875H857.365Z" fill="currentColor"></path></svg></a></div><div class="mx-auto flex w-full"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 border-input text-primary hover:border-primary/15 border hover:bg-overlay-hover py-2 max-w-full px-3 shadow-none sm:w-80 focus-visible:z-1 mx-auto h-full w-full rounded-full bg-surface-l1" type="button"><div class="flex items-center justify-between sm:w-full gap-4"><div class="flex items-center justify-start gap-2"><span class="inline-flex items-center justify-center p-0 m-0 w-4 h-4 text-muted" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-4 h-4" focusable="false" style="fill:currentColor"><path d="m18.031 16.617 4.283 4.282-1.415 1.415-4.282-4.283A8.96 8.96 0 0 1 11 20c-4.968 0-9-4.032-9-9s4.032-9 9-9 9 4.032 9 9a8.96 8.96 0 0 1-1.969 5.617m-2.006-.742A6.98 6.98 0 0 0 18 11c0-3.867-3.133-7-7-7s-7 3.133-7 7 3.133 7 7 7a6.98 6.98 0 0 0 4.875-1.975z"></path></svg></span><p class="text-sm text-muted hidden sm:block">Search</p></div><span class="hidden sm:block"><div class="bg-foreground/10 text-muted inline-flex items-center rounded-md px-1 py-0.5 text-center font-sans text-xs font-normal tracking-widest rtl:space-x-reverse"><span>⌘</span><span class="text-xs">K</span></div></span></div></button></div><div class="flex items-center gap-2 justify-self-end"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover px-4 py-2 w-9 h-9 flex-shrink-0" type="button" id="radix-_R_7apfiumdb_" aria-haspopup="menu" aria-expanded="false" data-state="closed"><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 rotate-0 scale-100 transition-all dark:-rotate-90 dark:scale-0" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M12 18a6 6 0 1 1 0-12 6 6 0 0 1 0 12m0-2a4 4 0 1 0 0-8 4 4 0 0 0 0 8M11 1h2v3h-2zm0 19h2v3h-2zM3.515 4.929l1.414-1.414L7.05 5.636 5.636 7.05zM16.95 18.364l1.414-1.414 2.121 2.121-1.414 1.414zm2.121-14.85 1.414 1.415-2.121 2.121-1.414-1.414zM5.636 16.95l1.414 1.414-2.121 2.121-1.414-1.414zM23 11v2h-3v-2zM4 11v2H1v-2z"></path></svg></span><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 absolute rotate-90 scale-0 transition-all dark:rotate-0 dark:scale-100" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M10 7a7 7 0 0 0 12 4.9v.1c0 5.523-4.477 10-10 10S2 17.523 2 12 6.477 2 12 2h.1A6.98 6.98 0 0 0 10 7m-6 5a8 8 0 0 0 15.062 3.762A9 9 0 0 1 8.238 4.938 8 8 0 0 0 4 12"></path></svg></span><span class="sr-only">Toggle theme</span></button></div></div><div class="flex h-full items-center md:hidden justify-between max-w-full py-6 px-4 w-full mx-auto pt-8"><div class="flex items-center"><div class="-ml-2"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover h-9 w-9" type="button" aria-label="Toggle table of contents"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-list h-6 w-6"><path d="M3 12h.01"></path><path d="M3 18h.01"></path><path d="M3 6h.01"></path><path d="M8 12h13"></path><path d="M8 18h13"></path><path d="M8 6h13"></path></svg></button></div><a class="cursor-pointer" href="/"><svg width="160" height="auto" viewBox="0 0 955 225" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M99.6937 159.214C90.008 159.214 81.5652 157.414 74.3652 153.814C67.1652 150.214 61.5509 144.986 57.5223 138.129C53.5794 131.271 51.608 123.043 51.608 113.443C51.608 103.843 53.5794 95.4857 57.5223 88.3714C61.5509 81.2572 67.1652 75.7286 74.3652 71.7857C81.6509 67.8429 90.1794 65.8714 99.9509 65.8714C103.208 65.8714 106.679 66.1286 110.365 66.6429C114.051 67.0714 117.222 67.6714 119.879 68.4429C121.508 68.8714 123.008 69.2572 124.379 69.6C125.751 69.9429 127.122 70.1143 128.494 70.1143C129.522 70.1143 130.551 69.9857 131.579 69.7286C131.751 73.5 131.922 77.4 132.094 81.4286C132.265 85.4572 132.522 89.6572 132.865 94.0286C131.065 94.2857 129.565 94.3714 128.365 94.2857C126.651 86.4 123.522 80.5714 118.979 76.8C114.437 72.9429 108.394 71.0143 100.851 71.0143C94.8509 71.0143 89.708 72.1286 85.4223 74.3572C81.2223 76.5 77.7937 79.4572 75.1366 83.2286C72.5652 87 70.6794 91.3714 69.4794 96.3429C68.2794 101.229 67.6794 106.457 67.6794 112.029C67.6794 120.171 68.9223 127.371 71.408 133.629C73.8937 139.886 77.6652 144.814 82.7223 148.414C87.8652 151.929 94.2937 153.686 102.008 153.686C104.408 153.686 107.065 153.471 109.979 153.043C112.894 152.529 115.679 151.757 118.337 150.729V134.529C118.337 131.871 118.208 129.814 117.951 128.357C117.779 126.814 117.222 125.7 116.279 125.014C115.422 124.329 114.008 123.857 112.037 123.6C110.151 123.257 107.537 122.957 104.194 122.7C103.937 121.329 103.937 119.957 104.194 118.586C105.994 118.586 108.179 118.629 110.751 118.714C113.322 118.714 115.894 118.757 118.465 118.843C121.122 118.843 123.308 118.843 125.022 118.843C127.679 118.843 130.722 118.8 134.151 118.714C137.665 118.629 140.665 118.586 143.151 118.586C143.322 119.871 143.322 121.2 143.151 122.571C139.637 123 137.108 123.429 135.565 123.857C134.022 124.286 133.079 125.143 132.737 126.429C132.394 127.714 132.222 129.9 132.222 132.986V137.1C132.222 141.129 132.308 144.514 132.479 147.257C132.737 150 132.951 151.971 133.122 153.171C121.208 157.2 110.065 159.214 99.6937 159.214ZM148.19 157.414C147.933 156.043 147.933 154.714 148.19 153.429C151.105 153.257 153.248 153 154.619 152.657C155.99 152.229 156.89 151.371 157.319 150.086C157.748 148.8 157.962 146.743 157.962 143.914V115.114C157.962 111.771 157.79 109.286 157.448 107.657C157.19 106.029 156.376 104.914 155.005 104.314C153.719 103.629 151.49 103.071 148.319 102.643C148.062 101.443 148.062 100.329 148.319 99.3C151.748 98.6143 155.09 97.8429 158.348 96.9857C161.605 96.0429 165.033 94.8429 168.633 93.3857L170.819 94.1572V105.471C176.819 97.8429 182.948 94.0286 189.205 94.0286C192.205 94.0286 194.433 94.8429 195.89 96.4714C197.348 98.0143 198.076 99.7714 198.076 101.743C198.076 104.057 197.305 105.857 195.762 107.143C194.219 108.343 192.462 108.943 190.49 108.943C188.862 108.943 187.233 108.514 185.605 107.657C184.062 106.8 182.905 105.471 182.133 103.671C179.219 103.671 176.605 104.829 174.29 107.143C172.062 109.371 170.948 111.986 170.948 114.986V142.629C170.948 145.971 171.119 148.371 171.462 149.829C171.89 151.286 172.919 152.229 174.548 152.657C176.262 153 179.005 153.257 182.776 153.429C182.948 154.629 182.948 155.957 182.776 157.414C179.862 157.414 176.862 157.371 173.776 157.286C170.69 157.2 167.519 157.157 164.262 157.157C161.09 157.157 158.262 157.2 155.776 157.286C153.376 157.371 150.848 157.414 148.19 157.414ZM229.285 158.829C223.028 158.829 217.542 157.5 212.828 154.843C208.199 152.1 204.599 148.371 202.028 143.657C199.457 138.857 198.171 133.371 198.171 127.2C198.171 120.514 199.499 114.686 202.157 109.714C204.899 104.743 208.714 100.886 213.599 98.1429C218.485 95.4 224.099 94.0286 230.442 94.0286C236.699 94.0286 242.142 95.4 246.771 98.1429C251.399 100.886 254.999 104.657 257.571 109.457C260.142 114.257 261.428 119.7 261.428 125.786C261.428 132.043 260.057 137.7 257.314 142.757C254.657 147.729 250.928 151.671 246.128 154.586C241.328 157.414 235.714 158.829 229.285 158.829ZM212.699 125.657C212.699 134.4 214.114 141.343 216.942 146.486C219.857 151.543 224.185 154.071 229.928 154.071C235.414 154.071 239.614 151.671 242.528 146.871C245.442 141.986 246.899 135.471 246.899 127.329C246.899 118.671 245.442 111.771 242.528 106.629C239.614 101.486 235.371 98.9143 229.799 98.9143C224.314 98.9143 220.071 101.271 217.071 105.986C214.157 110.7 212.699 117.257 212.699 125.657ZM267.394 157.414C267.308 157.071 267.265 156.729 267.265 156.386C267.265 156.043 267.265 155.7 267.265 155.357C267.265 155.014 267.265 154.714 267.265 154.457C267.265 154.114 267.308 153.771 267.394 153.429C270.308 153.257 272.451 153 273.822 152.657C275.194 152.229 276.094 151.371 276.522 150.086C276.951 148.8 277.165 146.743 277.165 143.914V79.5C277.165 76.8429 276.908 74.8714 276.394 73.5857C275.965 72.2143 274.979 71.2714 273.437 70.7572C271.979 70.1572 269.751 69.7286 266.751 69.4714C266.665 69.1286 266.622 68.8286 266.622 68.5714C266.622 68.3143 266.622 68.0572 266.622 67.8C266.622 67.4572 266.622 67.1572 266.622 66.9C266.622 66.6429 266.665 66.3429 266.751 66C270.179 65.5714 273.694 64.9286 277.294 64.0714C280.894 63.1286 284.579 61.8429 288.351 60.2143L290.537 60.9857C290.451 62.8714 290.365 65.0143 290.279 67.4143C290.279 69.8143 290.279 72.4286 290.279 75.2572V122.957C291.308 122.957 292.165 122.786 292.851 122.443C293.537 122.1 294.094 121.757 294.522 121.414C294.694 121.243 295.037 120.943 295.551 120.514C296.065 120 296.965 119.1 298.251 117.814C299.537 116.529 301.379 114.6 303.779 112.029C306.008 109.543 307.765 107.614 309.051 106.243C310.422 104.786 311.108 103.586 311.108 102.643C311.108 101.957 310.508 101.4 309.308 100.971C308.194 100.457 306.651 100.157 304.679 100.071C304.594 99.7286 304.551 99.3857 304.551 99.0429C304.551 98.7 304.551 98.3572 304.551 98.0143C304.551 97.6714 304.551 97.3286 304.551 96.9857C304.551 96.6429 304.594 96.3 304.679 95.9572C306.394 95.9572 308.537 96 311.108 96.0857C313.765 96.1714 316.122 96.2143 318.179 96.2143C319.208 96.2143 320.665 96.2143 322.551 96.2143C324.522 96.1286 326.494 96.0857 328.465 96.0857C330.437 96.0857 331.894 96.0857 332.837 96.0857C332.922 96.4286 332.965 96.7714 332.965 97.1143C333.051 97.4572 333.094 97.8 333.094 98.1429C333.094 98.4857 333.051 98.8286 332.965 99.1714C332.965 99.4286 332.922 99.7286 332.837 100.071C328.379 100.157 324.608 101.271 321.522 103.414C318.437 105.471 315.479 107.914 312.651 110.743L303.394 120L321.137 143.4C323.022 145.886 324.565 147.857 325.765 149.314C327.051 150.686 328.422 151.671 329.879 152.271C331.337 152.871 333.351 153.257 335.922 153.429C336.094 154.629 336.094 155.957 335.922 157.414C334.808 157.414 333.137 157.371 330.908 157.286C328.765 157.2 325.379 157.157 320.751 157.157C320.065 157.157 319.037 157.157 317.665 157.157C316.294 157.157 315.008 157.243 313.808 157.414C313.808 156.471 313.294 155.186 312.265 153.557C311.237 151.843 310.422 150.6 309.822 149.829C309.565 149.4 308.922 148.5 307.894 147.129C306.865 145.671 305.622 144 304.165 142.114C302.794 140.143 301.379 138.171 299.922 136.2C298.465 134.143 297.137 132.343 295.937 130.8C294.994 129.514 294.094 128.529 293.237 127.843C292.465 127.071 291.479 126.686 290.279 126.686V142.629C290.279 145.971 290.408 148.371 290.665 149.829C291.008 151.286 291.737 152.229 292.851 152.657C294.051 153 295.851 153.257 298.251 153.429C298.422 154.714 298.422 156.043 298.251 157.414C296.022 157.414 293.665 157.371 291.179 157.286C288.779 157.2 286.165 157.157 283.337 157.157C280.594 157.157 277.894 157.2 275.237 157.286C272.579 157.371 269.965 157.414 267.394 157.414ZM369.34 157.414C366.94 157.414 364.454 157.371 361.883 157.286C359.311 157.2 356.526 157.157 353.526 157.157C350.783 157.157 347.997 157.2 345.169 157.286C342.426 157.371 339.769 157.414 337.197 157.414C336.94 156.043 336.94 154.714 337.197 153.429C340.111 153.257 342.254 153 343.626 152.657C344.997 152.229 345.897 151.371 346.326 150.086C346.754 148.8 346.969 146.743 346.969 143.914V115.114C346.969 111.771 346.84 109.286 346.583 107.657C346.326 106.029 345.511 104.914 344.14 104.314C342.854 103.629 340.583 103.071 337.326 102.643C337.069 101.443 337.069 100.329 337.326 99.3C341.097 98.6143 344.697 97.7572 348.126 96.7286C351.554 95.7 354.854 94.5857 358.026 93.3857L360.211 94.1572C360.126 96.8143 360.04 99.3 359.954 101.614C359.954 103.929 359.954 106.114 359.954 108.171V142.629C359.954 145.971 360.126 148.371 360.469 149.829C360.897 151.286 361.754 152.229 363.04 152.657C364.411 153 366.511 153.257 369.34 153.429C369.597 154.714 369.597 156.043 369.34 157.414ZM343.626 71.5286C343.626 69.0429 344.483 66.9429 346.197 65.2286C347.997 63.5143 350.14 62.6572 352.626 62.6572C355.026 62.6572 357.083 63.5143 358.797 65.2286C360.597 66.9429 361.497 69 361.497 71.4C361.497 73.6286 360.64 75.6857 358.926 77.5715C357.211 79.3714 355.026 80.2714 352.369 80.2714C349.969 80.2714 347.911 79.4143 346.197 77.7C344.483 75.9857 343.626 73.9286 343.626 71.5286ZM372.678 188.914C372.592 187.543 372.592 186.214 372.678 184.929C375.678 184.757 377.864 184.457 379.235 184.029C380.607 183.6 381.464 182.743 381.807 181.457C382.235 180.257 382.45 178.286 382.45 175.543V115.114C382.45 111.771 382.278 109.286 381.935 107.657C381.678 106.029 380.864 104.914 379.492 104.314C378.207 103.629 375.978 103.071 372.807 102.643C372.635 101.443 372.635 100.329 372.807 99.3C376.321 98.6143 379.75 97.8 383.092 96.8572C386.435 95.9143 389.907 94.7572 393.507 93.3857L395.307 94.2857C395.221 96.4286 395.178 98.2714 395.178 99.8143C395.178 101.271 395.178 102.686 395.178 104.057C398.521 100.543 401.821 98.0143 405.078 96.4714C408.335 94.8429 411.807 94.0286 415.492 94.0286C420.892 94.0286 425.435 95.4429 429.121 98.2714C432.892 101.1 435.764 104.786 437.735 109.329C439.707 113.871 440.692 118.8 440.692 124.114C440.692 130.371 439.321 136.157 436.578 141.471C433.921 146.7 430.192 150.9 425.392 154.071C420.592 157.243 415.021 158.829 408.678 158.829C406.192 158.829 403.835 158.614 401.607 158.186C399.378 157.843 397.278 157.329 395.307 156.643V174C395.307 177.343 395.564 179.743 396.078 181.2C396.592 182.657 397.707 183.557 399.421 183.9C401.135 184.329 403.835 184.629 407.521 184.8C407.607 186.171 407.607 187.543 407.521 188.914C404.607 188.914 401.65 188.871 398.65 188.786C395.735 188.7 392.521 188.657 389.007 188.657C385.664 188.657 382.792 188.7 380.392 188.786C377.992 188.871 375.421 188.914 372.678 188.914ZM395.178 146.1C398.864 151.414 403.75 154.071 409.835 154.071C414.121 154.071 417.507 152.871 419.992 150.471C422.564 148.071 424.407 144.943 425.521 141.086C426.721 137.229 427.321 133.157 427.321 128.871C427.321 124.586 426.764 120.386 425.65 116.271C424.535 112.157 422.692 108.771 420.121 106.114C417.635 103.371 414.207 102 409.835 102C404.607 102 399.721 104.529 395.178 109.586V146.1ZM477.335 158.829C471.25 158.829 466.107 157.414 461.907 154.586C457.707 151.757 454.493 147.986 452.264 143.271C450.121 138.471 449.05 133.2 449.05 127.457C449.05 121.543 450.164 116.057 452.393 111C454.707 105.943 458.05 101.871 462.421 98.7857C466.793 95.6143 472.107 94.0286 478.364 94.0286C485.907 94.0286 491.778 96.3 495.978 100.843C500.264 105.3 502.407 111.086 502.407 118.2C502.407 119.057 502.364 119.829 502.278 120.514C502.278 121.114 502.235 121.629 502.15 122.057L461.65 121.671C461.65 122.014 461.65 122.314 461.65 122.571C461.65 130.971 463.578 137.571 467.435 142.371C471.293 147.171 476.693 149.571 483.635 149.571C489.464 149.571 495.207 147.686 500.864 143.914C501.721 144.943 502.364 145.929 502.793 146.871C495.507 154.843 487.021 158.829 477.335 158.829ZM462.035 116.914L488.65 116.4C488.735 116.229 488.778 116.014 488.778 115.757C488.778 115.414 488.778 115.2 488.778 115.114C488.778 110.486 487.75 106.629 485.693 103.543C483.721 100.457 480.764 98.9143 476.821 98.9143C473.135 98.9143 469.921 100.414 467.178 103.414C464.435 106.414 462.721 110.914 462.035 116.914ZM559.644 158.957L557.587 158.057L557.073 149.186C554.073 152.443 550.987 154.886 547.816 156.514C544.73 158.057 541.302 158.829 537.53 158.829C532.216 158.829 527.544 157.414 523.516 154.586C519.573 151.671 516.53 147.9 514.387 143.271C512.244 138.643 511.173 133.629 511.173 128.229C511.173 121.971 512.502 116.271 515.159 111.129C517.902 105.986 521.716 101.871 526.602 98.7857C531.573 95.6143 537.359 94.0286 543.959 94.0286C545.93 94.0286 547.987 94.2 550.13 94.5429C552.273 94.8 554.502 95.2714 556.816 95.9572V79.5C556.816 76.8429 556.559 74.8714 556.044 73.5857C555.53 72.2143 554.502 71.2714 552.959 70.7572C551.502 70.1572 549.273 69.7286 546.273 69.4714C546.016 68.3572 546.016 67.2 546.273 66C549.702 65.5714 553.216 64.9286 556.816 64.0714C560.416 63.1286 564.102 61.8429 567.873 60.2143L570.059 60.9857C569.973 62.8714 569.887 65.0143 569.802 67.4143C569.802 69.8143 569.802 72.4286 569.802 75.2572V139.029C569.802 142.286 569.93 144.729 570.187 146.357C570.445 147.986 571.216 149.143 572.502 149.829C573.787 150.429 575.973 150.986 579.059 151.5C579.316 152.614 579.316 153.771 579.059 154.971C575.63 155.486 572.287 156.043 569.03 156.643C565.773 157.243 562.644 158.014 559.644 158.957ZM556.944 106.886C553.259 101.829 548.416 99.3 542.416 99.3C536.502 99.3 532.044 101.486 529.044 105.857C526.044 110.143 524.544 116.1 524.544 123.729C524.544 128.186 525.144 132.471 526.344 136.586C527.544 140.7 529.516 144.086 532.259 146.743C535.002 149.4 538.644 150.729 543.187 150.729C548.93 150.729 553.516 148.243 556.944 143.271V106.886ZM615.699 157.414C613.299 157.414 610.813 157.371 608.242 157.286C605.67 157.2 602.885 157.157 599.885 157.157C597.142 157.157 594.356 157.2 591.527 157.286C588.785 157.371 586.127 157.414 583.556 157.414C583.299 156.043 583.299 154.714 583.556 153.429C586.47 153.257 588.613 153 589.985 152.657C591.356 152.229 592.256 151.371 592.685 150.086C593.113 148.8 593.327 146.743 593.327 143.914V115.114C593.327 111.771 593.199 109.286 592.942 107.657C592.685 106.029 591.87 104.914 590.499 104.314C589.213 103.629 586.942 103.071 583.685 102.643C583.427 101.443 583.427 100.329 583.685 99.3C587.456 98.6143 591.056 97.7572 594.485 96.7286C597.913 95.7 601.213 94.5857 604.385 93.3857L606.57 94.1572C606.485 96.8143 606.399 99.3 606.313 101.614C606.313 103.929 606.313 106.114 606.313 108.171V142.629C606.313 145.971 606.485 148.371 606.827 149.829C607.256 151.286 608.113 152.229 609.399 152.657C610.77 153 612.87 153.257 615.699 153.429C615.956 154.714 615.956 156.043 615.699 157.414ZM589.985 71.5286C589.985 69.0429 590.842 66.9429 592.556 65.2286C594.356 63.5143 596.499 62.6572 598.985 62.6572C601.385 62.6572 603.442 63.5143 605.156 65.2286C606.956 66.9429 607.856 69 607.856 71.4C607.856 73.6286 606.999 75.6857 605.285 77.5715C603.57 79.3714 601.385 80.2714 598.727 80.2714C596.327 80.2714 594.27 79.4143 592.556 77.7C590.842 75.9857 589.985 73.9286 589.985 71.5286ZM665.837 158.571C660.18 158.571 656.623 155.743 655.165 150.086C649.08 155.914 642.865 158.829 636.523 158.829C632.151 158.829 628.423 157.543 625.337 154.971C622.337 152.314 620.837 148.671 620.837 144.043C620.837 132.729 632.365 125.614 655.423 122.7C655.423 120.643 655.423 118.543 655.423 116.4C655.508 114.257 655.551 111.986 655.551 109.586C655.551 106.586 654.437 104.271 652.208 102.643C650.065 100.929 647.451 100.071 644.365 100.071C642.137 100.071 640.251 100.414 638.708 101.1C638.708 103.071 638.28 105.086 637.423 107.143C636.565 109.2 635.365 110.957 633.823 112.414C632.365 113.786 630.565 114.471 628.423 114.471C626.537 114.471 625.037 113.957 623.923 112.929C622.894 111.814 622.38 110.486 622.38 108.943C622.38 106.886 623.323 104.957 625.208 103.157C627.18 101.271 629.665 99.6857 632.665 98.4C635.665 97.0286 638.794 95.9572 642.051 95.1857C645.308 94.4143 648.223 94.0286 650.794 94.0286C653.965 94.0286 656.88 94.6286 659.537 95.8286C662.28 96.9429 664.465 98.6572 666.094 100.971C667.808 103.2 668.665 105.986 668.665 109.329C668.665 111.386 668.623 114.086 668.537 117.429C668.451 120.686 668.365 124.2 668.28 127.971C668.28 131.657 668.237 135.171 668.151 138.514C668.065 141.857 668.023 144.557 668.023 146.614C668.023 149.357 669.223 150.729 671.623 150.729C673.165 150.729 675.523 150.214 678.694 149.186C679.037 149.614 679.251 150.086 679.337 150.6C679.508 151.114 679.637 151.586 679.723 152.014C677.58 154.329 675.308 156 672.908 157.029C670.594 158.057 668.237 158.571 665.837 158.571ZM655.165 146.614L655.423 127.329C647.537 128.357 642.094 130.029 639.094 132.343C636.18 134.657 634.723 137.614 634.723 141.214C634.723 144.214 635.494 146.529 637.037 148.157C638.665 149.7 640.68 150.471 643.08 150.471C644.623 150.471 646.337 150.129 648.223 149.443C650.194 148.757 652.508 147.814 655.165 146.614Z" fill="currentColor"></path><rect x="715" y="65" width="195" height="105" rx="52.5" fill="currentColor" fill-opacity="0.05"></rect><path d="M767.529 142.875L754.049 107.938H762.552L769.309 127.582C769.705 128.812 770.078 130.032 770.43 131.24C770.781 132.449 771.078 133.559 771.32 134.569H771.616C771.858 133.559 772.144 132.449 772.473 131.24C772.825 130.032 773.198 128.812 773.594 127.582L780.186 107.938H788.689L775.472 142.875H767.529ZM810.856 143.633C806.901 143.633 803.528 142.71 800.737 140.865C797.969 138.997 795.871 136.305 794.442 132.79C793.014 129.252 792.3 124.989 792.3 120.001V118.255C792.3 113.245 793.014 108.982 794.442 105.467C795.871 101.929 797.969 99.2373 800.737 97.3916C803.528 95.5239 806.901 94.5901 810.856 94.5901C814.789 94.5901 818.129 95.5129 820.875 97.3586C823.644 99.2043 825.731 101.907 827.138 105.467C828.566 109.004 829.28 113.267 829.28 118.255V120.001C829.28 124.989 828.577 129.252 827.171 132.79C825.764 136.327 823.677 139.019 820.908 140.865C818.162 142.71 814.811 143.633 810.856 143.633ZM810.889 136.382C813.064 136.382 814.877 135.789 816.327 134.602C817.799 133.416 818.898 131.658 819.623 129.329C820.348 126.978 820.711 124.066 820.711 120.595V117.694C820.711 114.223 820.337 111.311 819.59 108.96C818.865 106.609 817.777 104.84 816.327 103.654C814.877 102.445 813.064 101.841 810.889 101.841C808.714 101.841 806.879 102.434 805.385 103.621C803.912 104.785 802.792 106.554 802.023 108.927C801.276 111.278 800.902 114.201 800.902 117.694V120.595C800.902 124.044 801.287 126.945 802.056 129.296C802.825 131.647 803.945 133.416 805.418 134.602C806.89 135.789 808.714 136.382 810.889 136.382ZM838.988 143.205C838 143.205 837.099 142.985 836.286 142.545C835.495 142.106 834.879 141.491 834.44 140.7C834.001 139.909 833.781 139.019 833.781 138.03C833.781 137.019 834.001 136.118 834.44 135.327C834.879 134.536 835.495 133.921 836.286 133.482C837.099 133.042 838 132.823 838.988 132.823C839.977 132.823 840.867 133.042 841.658 133.482C842.449 133.921 843.064 134.536 843.504 135.327C843.943 136.118 844.163 137.019 844.163 138.03C844.163 139.019 843.943 139.909 843.504 140.7C843.064 141.491 842.449 142.106 841.658 142.545C840.867 142.985 839.977 143.205 838.988 143.205ZM857.365 142.875V104.511L846.39 111.663V103.357L858.453 95.3481H865.802V142.875H857.365Z" fill="currentColor"></path></svg></a></div><div class="flex items-center gap-1"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover px-4 py-2 w-9 h-9 flex-shrink-0 [&amp;_svg]:!w-5" type="button" id="radix-_R_aipfiumdb_" aria-haspopup="menu" aria-expanded="false" data-state="closed"><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 rotate-0 scale-100 transition-all dark:-rotate-90 dark:scale-0" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M12 18a6 6 0 1 1 0-12 6 6 0 0 1 0 12m0-2a4 4 0 1 0 0-8 4 4 0 0 0 0 8M11 1h2v3h-2zm0 19h2v3h-2zM3.515 4.929l1.414-1.414L7.05 5.636 5.636 7.05zM16.95 18.364l1.414-1.414 2.121 2.121-1.414 1.414zm2.121-14.85 1.414 1.415-2.121 2.121-1.414-1.414zM5.636 16.95l1.414 1.414-2.121 2.121-1.414-1.414zM23 11v2h-3v-2zM4 11v2H1v-2z"></path></svg></span><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 absolute rotate-90 scale-0 transition-all dark:rotate-0 dark:scale-100" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M10 7a7 7 0 0 0 12 4.9v.1c0 5.523-4.477 10-10 10S2 17.523 2 12 6.477 2 12 2h.1A6.98 6.98 0 0 0 10 7m-6 5a8 8 0 0 0 15.062 3.762A9 9 0 0 1 8.238 4.938 8 8 0 0 0 4 12"></path></svg></span><span class="sr-only">Toggle theme</span></button><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover h-9 w-9" type="button"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-search h-5 w-5"><circle cx="11" cy="11" r="8"></circle><path d="m21 21-4.3-4.3"></path></svg></button></div></div></header><div class="bg-surface-base fixed right-0 top-16 z-50 h-[calc(100vh-4rem)] w-full transform border-l transition-transform duration-300 ease-in-out sm:w-1/2 md:hidden translate-x-full"><div class="flex flex-col gap-4 p-4"><div class="flex flex-row gap-2"><button class="focus-visible:ring-ring inline-flex items-center gap-x-2 whitespace-nowrap text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 border-input text-primary hover:border-primary/15 border hover:bg-overlay-hover py-2 max-w-full shadow-none sm:w-80 h-10 w-full justify-start rounded-full bg-surface-l1 px-4" type="button"><div class="flex items-center justify-between sm:w-full gap-4"><div class="flex items-center justify-start gap-2"><span class="inline-flex items-center justify-center p-0 m-0 w-4 h-4 text-muted" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-4 h-4" focusable="false" style="fill:currentColor"><path d="m18.031 16.617 4.283 4.282-1.415 1.415-4.282-4.283A8.96 8.96 0 0 1 11 20c-4.968 0-9-4.032-9-9s4.032-9 9-9 9 4.032 9 9a8.96 8.96 0 0 1-1.969 5.617m-2.006-.742A6.98 6.98 0 0 0 18 11c0-3.867-3.133-7-7-7s-7 3.133-7 7 3.133 7 7 7a6.98 6.98 0 0 0 4.875-1.975z"></path></svg></span><p class="text-sm text-muted hidden sm:block">Search</p></div><span class="hidden sm:block"><div class="bg-foreground/10 text-muted inline-flex items-center rounded-md px-1 py-0.5 text-center font-sans text-xs font-normal tracking-widest rtl:space-x-reverse"><span>⌘</span><span class="text-xs">K</span></div></span></div></button></div></div></div><div><div class="min-[1350px]:grid min-[1350px]:grid-cols-[1fr_3fr_1fr]"><nav class="bg-surface-base hidden h-[calc(100vh-4rem)] overflow-y-auto px-6 pb-32 min-[1350px]:sticky min-[1350px]:top-16 min-[1350px]:block scrollbar-none [-ms-overflow-style:none] [scrollbar-width:none] [&amp;::-webkit-scrollbar]:hidden [overscroll-behavior:contain] pt-8"><ul class="space-y-2 text-sm"><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#list-of-countries-by-prevalence-of-opiates-use" class="transition-opacity hover:opacity-100 opacity-50">List of countries by prevalence of opiates use</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#definitions-and-measurement" class="transition-opacity hover:opacity-100 opacity-50">Definitions and Measurement</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#scope-of-opiates-and-exclusions" class="transition-opacity hover:opacity-100 opacity-50">Scope of Opiates and Exclusions</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#prevalence-indicators-and-age-groups" class="transition-opacity hover:opacity-100 opacity-50">Prevalence Indicators and Age Groups</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#data-sources-and-methodology" class="transition-opacity hover:opacity-100 opacity-50">Data Sources and Methodology</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#primary-international-sources" class="transition-opacity hover:opacity-100 opacity-50">Primary International Sources</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#national-surveys-and-estimation-techniques" class="transition-opacity hover:opacity-100 opacity-50">National Surveys and Estimation Techniques</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#limitations-of-available-data" class="transition-opacity hover:opacity-100 opacity-50">Limitations of Available Data</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#underreporting-and-detection-biases" class="transition-opacity hover:opacity-100 opacity-50">Underreporting and Detection Biases</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#temporal-and-definitional-inconsistencies" class="transition-opacity hover:opacity-100 opacity-50">Temporal and Definitional Inconsistencies</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#global-and-regional-patterns" class="transition-opacity hover:opacity-100 opacity-50">Global and Regional Patterns</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#worldwide-prevalence-estimates" class="transition-opacity hover:opacity-100 opacity-50">Worldwide Prevalence Estimates</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#high-prevalence-regions-and-explanations" class="transition-opacity hover:opacity-100 opacity-50">High-Prevalence Regions and Explanations</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#country-specific-prevalence-data" class="transition-opacity hover:opacity-100 opacity-50">Country-Specific Prevalence Data</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#highest-prevalence-countries" class="transition-opacity hover:opacity-100 opacity-50">Highest Prevalence Countries</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#lowest-prevalence-countries" class="transition-opacity hover:opacity-100 opacity-50">Lowest Prevalence Countries</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#full-ranked-list" class="transition-opacity hover:opacity-100 opacity-50">Full Ranked List</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#correlates-and-causal-factors" class="transition-opacity hover:opacity-100 opacity-50">Correlates and Causal Factors</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#socioeconomic-and-geographic-influences" class="transition-opacity hover:opacity-100 opacity-50">Socioeconomic and Geographic Influences</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#drug-policy-enforcement-effects" class="transition-opacity hover:opacity-100 opacity-50">Drug Policy Enforcement Effects</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#debates-on-data-interpretation" class="transition-opacity hover:opacity-100 opacity-50">Debates on Data Interpretation</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#reliability-of-estimates-in-restrictive-regimes" class="transition-opacity hover:opacity-100 opacity-50">Reliability of Estimates in Restrictive Regimes</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#policy-efficacy-versus-reported-prevalence" class="transition-opacity hover:opacity-100 opacity-50">Policy Efficacy Versus Reported Prevalence</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#references" class="transition-opacity hover:opacity-100 opacity-50">References</a></li></ul></nav><div class="relative top-16 pb-32 pt-8 px-4 md:px-8"><div class="mx-auto max-w-[850px]"><button data-state="closed" type="button" class="flex items-center"><div class="text-fg-tertiary mb-2 flex cursor-help items-center gap-2 text-sm"><span class="inline-flex items-center justify-center p-0 m-0" data-namespace="@xai/icons" data-slot="icon" style="height:16px;width:16px"><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 33 33" aria-hidden="true" class="" focusable="false" style="fill:currentColor;height:16px;width:16px"><path fill="currentColor" d="m13.237 21.04 11.082-8.19c.543-.4 1.32-.244 1.578.38 1.363 3.288.754 7.241-1.957 9.955-2.71 2.714-6.482 3.31-9.93 1.954l-3.765 1.745c5.401 3.697 11.96 2.782 16.059-1.324 3.251-3.255 4.258-7.692 3.317-11.693l.008.009c-1.365-5.878.336-8.227 3.82-13.031q.123-.17.247-.345l-4.585 4.59v-.014L13.234 21.044M10.95 23.031c-3.877-3.707-3.208-9.446.1-12.755 2.446-2.449 6.454-3.448 9.952-1.979L24.76 6.56c-.677-.49-1.545-1.017-2.54-1.387A12.465 12.465 0 0 0 8.675 7.901c-3.519 3.523-4.625 8.94-2.725 13.561 1.42 3.454-.907 5.898-3.251 8.364-.83.874-1.664 1.749-2.335 2.674l10.583-9.466"></path></svg></span><span>Fact-checked by Grok<!-- --> <!-- -->4 days ago</span></div></button><article class="text-[16px]"><h1 id="list-of-countries-by-prevalence-of-opiates-use" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">List of countries by prevalence of opiates use<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<span class="mb-4 block break-words text-[1em] leading-7">
The list of countries by prevalence of opiates use ranks nations based on the estimated annual prevalence rate of opiate consumption—encompassing substances like heroin, opium, and morphine—among the population aged 15–64, as compiled from national surveys, treatment records, and indirect indicators by the United Nations Office on Drugs and Crime (UNODC).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_60qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> These figures reflect past-year use and serve as a metric for assessing the scale of illicit opiate involvement relative to population size, highlighting geographic and socioeconomic patterns tied to production, transit, and demand.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a0qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Globally, opiate use affects approximately 31.5 million people, equating to a prevalence of about 0.6% of the adult population, with the vast majority of users concentrated in Asia due to proximity to primary production areas in Afghanistan and Myanmar.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_41abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup> Regional disparities are pronounced, with South Asia exhibiting a 1.1% prevalence—nearly double the worldwide average—and South-West Asia even higher at around 1.8%, driven by opium cultivation in the Golden Crescent and trafficking corridors.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_81abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a1abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup> Countries such as Iran, Pakistan, and those in Central Asia consistently rank among the highest, where factors including porous borders, economic hardship, and historical consumption patterns exacerbate use rates exceeding 1–2% in some estimates.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_e1abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The rankings underscore causal linkages between opiate prevalence and upstream supply dynamics, as nations adjacent to cultivation zones face elevated exposure through smuggling routes and local diversion, contrasting with lower rates in distant regions despite global distribution efforts by traffickers.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_41qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> Data reliability varies, with self-reported surveys prone to underestimation in stigmatized contexts and limited coverage in low-resource settings, yet UNODC&#x27;s aggregation provides the most systematic global benchmark.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_81qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup> This list informs policy by revealing that prevalence correlates more strongly with regional production hotspots than with demand-side interventions alone, challenging narratives that overemphasize isolated epidemics in high-income countries while regional data points to persistent supply-driven challenges in Asia.</span>
<h2 id="definitions-and-measurement" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Definitions and Measurement<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="scope-of-opiates-and-exclusions" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Scope of Opiates and Exclusions<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Opiates are defined as naturally occurring alkaloids extracted from the opium poppy <em>Papaver somniferum</em>, primarily including morphine, codeine, thebaine, and their semisynthetic derivatives such as heroin and oxycodone.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_83abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[7]</sup> This narrow scope excludes fully synthetic opioids, which mimic opiate effects through opioid receptor binding but lack natural derivation, such as fentanyl, methadone, tramadol, and pethidine.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c3abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[7]</sup> While media and public discourse frequently conflate opiates with the broader opioid category—encompassing both natural and synthetic substances—United Nations Office on Drugs and Crime (UNODC) monitoring distinguishes them to isolate trafficking and use patterns tied to opium production.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_g3abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[8]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Prevalence statistics for opiates emphasize illicit or non-medical use, defined as consumption without medical authorization or for purposes beyond prescribed therapeutic intent, often measured via past-year use indicators in population surveys.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_43qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup> Legitimate pharmaceutical dispensing of opiate-based analgesics, such as codeine for pain management, is excluded unless evidence indicates diversion, misuse, or dependence, aligning with UNODC&#x27;s focus on problematic patterns contributing to public health burdens like overdose and addiction.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_83qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup> This exclusion prevents inflation of figures from routine medical practices, which vary widely by healthcare access and do not reflect the illicit markets central to global opiate prevalence assessments.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c3qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[10]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The post-2010 surge in synthetic opioid availability, driven by pharmaceutical production and illicit analogs like fentanyl, prompted a terminological pivot in some international reporting toward &quot;opioids&quot; for aggregated analysis of receptor-agonist substances.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_44abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[11]</sup> Nonetheless, UNODC data retain the opiates-opioids distinction, with opiates (predominantly heroin) accounting for 31.5 million users out of 60 million in non-medical opioid use globally in 2021, representing roughly 52% of the opioid burden.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_84abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[12]</sup> This delineation underscores opiates&#x27; outsized role in regions reliant on opium cultivation, despite synthetics&#x27; rising dominance in overdose fatalities elsewhere.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c4abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[8]</sup></span>
<h3 id="prevalence-indicators-and-age-groups" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Prevalence Indicators and Age Groups<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">The primary indicator for measuring opiate prevalence across countries is past-year prevalence, defined as the percentage of the population aged 15-64 who report having used opiates at least once in the preceding 12 months.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_45abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup> This metric, standardized by the United Nations Office on Drugs and Crime (UNODC) since the early 2000s, enables consistent international comparisons by focusing on self-reported use from population-based surveys rather than indirect proxies like treatment admissions or seizures.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_85abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Prevalence estimates distinguish between lifetime use (ever having used opiates), past-year use (recent exposure), and past-month use (indicating more frequent or current patterns), with past-year serving as the benchmark for capturing both occasional and regular users while minimizing recall bias inherent in lifetime reports.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_45qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[13]</sup> UNODC prioritizes verifiable data from general population surveys, household-based where possible, over clinical or overdose statistics, as the latter reflect severe outcomes rather than overall incidence and are prone to undercounting non-fatal use.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_85qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">To derive absolute numbers of users, prevalence rates are multiplied by the size of the target population (aged 15-64), yielding global estimates such as approximately 31.5 million opiate users in 2021, distinct from broader opioid figures that include synthetics like fentanyl.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_46abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[12]</sup> This adjustment accounts for demographic variations but requires imputation for countries lacking direct surveys, using multipliers from neighboring regions or historical trends.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_86abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup></span>
<h2 id="data-sources-and-methodology" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Data Sources and Methodology<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="primary-international-sources" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Primary International Sources<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">The United Nations Office on Drugs and Crime (UNODC) produces the World Drug Report annually since 2000, establishing it as the benchmark international compilation for opiate prevalence estimates derived from aggregated national-level data, including household surveys and indirect indicators like treatment admissions. These reports estimate past-year opiate use (primarily heroin and opium) among individuals aged 15-64, reporting a global prevalence of approximately 0.6% in recent assessments, equivalent to around 31 million users in 2021.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_47qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[15]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_67qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup> The 2025 edition, released on June 26, 2025, integrates data through 2023, noting persistent opiate use patterns amid increasing adulteration with synthetic opioids like fentanyl, which complicates purity measurement but does not alter core prevalence aggregation methods.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a7qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[16]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c7qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[17]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The World Health Organization (WHO) supports UNODC through aligned global estimates on drug use disorders, contributing data on opioid dependence that informs opiate-specific subsets, with 2021 figures indicating about 60 million non-medical opioid users worldwide, half of whom used opiates.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_48abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[18]</sup> WHO&#x27;s methodologies emphasize epidemiological modeling for regions with sparse surveys, providing validation for UNODC&#x27;s regional breakdowns.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_88abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[18]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) offers supplementary regional data for Europe, harmonizing national reports to estimate opiate prevalence at around 0.4% for high-risk use among adults aged 15-64, often cross-referencing UNODC for global benchmarking.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_48qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[19]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_68qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup> EMCDDA&#x27;s 2024 European Drug Report details opiate indicators like wastewater analysis and overdose statistics to refine estimates.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a8qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[19]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Our World in Data aggregates UNODC prevalence figures into interactive visualizations, tracking opiate use trends from the early 2020s, such as stable global rates despite regional variations in Asia and Europe.</span>
<h3 id="national-surveys-and-estimation-techniques" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">National Surveys and Estimation Techniques<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">National drug use prevalence is primarily assessed through nationally representative household surveys, which use probabilistic sampling to self-report lifetime, past-year, or past-month opiate consumption among the general population, typically those aged 15-64. These surveys form the core of data submitted by member states via the United Nations Office on Drugs and Crime&#x27;s (UNODC) Annual Report Questionnaire (ARQ), a standardized aggregate reporting mechanism mandated under international drug control conventions and refined since the 2010s to improve consistency and coverage. However, household surveys often undercount opiate users due to the drug&#x27;s association with stigmatized, hidden high-risk populations, prompting reliance on supplementary indicators like school-based surveys for youth or specialized key informant interviews.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4aabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[20]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6aabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[21]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8aabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[22]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Estimation techniques emphasize triangulation of disparate sources to model total prevalence, combining household data with treatment admission records, law enforcement seizures, and indirect proxies for undetected use. For opiates, where direct surveys falter, multiplier methods derive total users from treatment seekers by applying context-specific ratios—such as benchmarks estimating untreated users based on administrative data like opioid agonist maintenance therapy enrollments—often indicating that only a minority of dependent individuals access formal care. Seizure data contributes indirectly by informing supply-side inferences, while capture-recapture and network scale-up approaches adjust for overlap and underreporting in hidden networks; data gaps in low-reporting countries are bridged via subregional imputation using weighted percentiles or regression extrapolations to facilitate cross-national comparability.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4aqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[21]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6aqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[22]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8aqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[23]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Methodological evolution has shifted from coarse 1990s extrapolations reliant on limited indicators to 2020s frameworks incorporating refined uncertainty ranges and underreporting corrections for factors like stigma, as detailed in UNODC&#x27;s iterative World Drug Reports since 1997. ARQ revisions post-2010 enhanced indirect estimation protocols, prioritizing problem drug use metrics over general population snapshots for opiates, thereby yielding more robust global aggregates through expert-validated adjustments rather than unadjusted survey raw data.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4babav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[22]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6babav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[24]</sup></span>
<h2 id="limitations-of-available-data" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Limitations of Available Data<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="underreporting-and-detection-biases" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Underreporting and Detection Biases<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Self-reported surveys, which form the backbone of many prevalence estimates for opiate use, are susceptible to underreporting due to social desirability bias and reluctance to disclose illicit behaviors. Validation studies comparing self-reports to biological markers like urine or hair tests have consistently shown that respondents underreport illicit drug use, including opiates, with discrepancies most pronounced for recent or ongoing consumption.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4cqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[25]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8cqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[26]</sup> This underreporting is amplified in jurisdictions with stringent enforcement regimes, where fear of prosecution or social stigma incentivizes concealment, as evidenced by higher discordance rates in criminal justice-involved samples.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ccqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[27]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gcqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[28]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The inherently clandestine nature of illicit opiate markets further obscures detection, as users often employ evasion tactics to avoid scrutiny, leading to incomplete capture in household or population-based surveys. Indirect indicators, such as overdose mortality statistics, primarily reflect acute endpoints rather than overall prevalence, systematically missing non-fatal or controlled use patterns that constitute the majority of consumption.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4dabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[29]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8dabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[30]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In the 2020s, the proliferation of synthetic opioids, including fentanyl analogs mixed into heroin supplies, has introduced additional detection hurdles, as these potent substances can occur in microgram quantities that evade standard toxicological screening protocols. This shift contributes to underestimation of prevalence, particularly in regions where adulteration is rampant but routine testing lacks sensitivity for novel variants.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4dqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[31]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8dqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[32]</sup></span>
<h3 id="temporal-and-definitional-inconsistencies" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Temporal and Definitional Inconsistencies<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Comparisons of opiate prevalence across countries are complicated by temporal lags in data collection and reporting, where estimates in recent global assessments often rely on surveys conducted several years earlier. For instance, the United Nations Office on Drugs and Crime&#x27;s (UNODC) World Drug Report 2025 incorporates prevalence figures primarily from 2021 or earlier for many nations, potentially undercapturing rapid shifts such as post-COVID-19 surges in opioid-related disorders reported in regions like North America and Europe, where isolation and economic disruptions exacerbated use patterns.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4eqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[16]</sup> In some low-resource countries, the most recent available data dates to the early 2000s or 2010s, reflecting infrequent national household surveys and leading to outdated snapshots that fail to account for evolving trafficking routes or policy interventions.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8eqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Definitional variations further hinder comparability, particularly the distinction between opiates and broader opioids. UNODC prevalence metrics focus predominantly on opiates—defined as natural and semi-synthetic substances like heroin, opium, and morphine—excluding synthetic opioids such as fentanyl and tramadol, which numbered approximately 28.5 million non-medical users globally in 2021 compared to 31.5 million opiate users.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4fabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[12]</sup> This narrow scope inflates relative opiate prevalence estimates in Asia and the Near East, where traditional opiates dominate, while understating overall opioid burdens in the Americas, where synthetics drive over 75% of overdose deaths; such mismatches arise because national surveys and UNODC harmonization prioritize opiate-specific indicators for consistency with treaty obligations, yet overlook the ~30 million synthetic users in cross-regional rankings.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8fabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_afabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[18]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Efforts to mitigate these issues include UNODC&#x27;s standardized estimation protocols, refined since the early 2010s through indirect methods like multiplier techniques and capture-recapture models when direct surveys are absent, but persistent gaps remain in data-sparse regions. Africa and Latin America, for example, suffer from survey intervals exceeding five years in many countries, compounded by underreporting in household polls that exclude high-risk populations like the homeless or incarcerated, thus perpetuating non-comparable aggregates despite global harmonization initiatives.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4fqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[23]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6fqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup></span>
<h2 id="global-and-regional-patterns" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Global and Regional Patterns<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="worldwide-prevalence-estimates" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Worldwide Prevalence Estimates<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">The global prevalence of past-year opiate use among individuals aged 15-64 years has remained stable at approximately 0.6% from 2010 to 2021, corresponding to an estimated 31.5 million users worldwide in 2021.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4habav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[12]</sup> Opiates, encompassing opium, heroin, and morphine, represent the traditional subset of opioid substances, distinct from synthetic opioids such as fentanyl, which have driven broader opioid trends in certain regions. This stability reflects consistent production patterns, primarily from Afghanistan and Myanmar, balanced against varying demand and enforcement efforts, though underreporting in producer and transit countries likely understates true figures.</span>
<span class="mb-4 block break-words text-[1em] leading-7">In the context of overall illicit drug use, opiates rank as the second most prevalent substance after cannabis, which affected 228 million past-year users in 2021.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4hqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> Total past-year drug users reached 296 million that year, or about 5.8% of the global 15-64 population, with opiates comprising roughly 10% of this total.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8hqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> Non-medical opioid use overall stood at 60 million, underscoring opiates&#x27; role amid rising synthetics, but opiate-specific estimates have not shown marked shifts pre-2022 due to methodological consistency in UNODC modeling, which integrates household surveys, treatment data, and seizure records.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_chqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Pandemic-related disruptions from 2020 onward introduced slight upticks in drug use indicators, including potential opiate access challenges from border closures, though global opiate prevalence data lags beyond 2021. The UNODC&#x27;s 2025 World Drug Report projects risks of elevated opiate use from instability in producer areas, notably following Afghanistan&#x27;s 95% opiate market contraction post-2022 Taliban restrictions, which may spur demand-driven price surges or shifts to unregulated synthetics, complicating future estimates.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4iabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[33]</sup> These trends highlight the need for enhanced monitoring, as supply shocks could reverse prior stability without adaptive interventions.</span>
<h3 id="high-prevalence-regions-and-explanations" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">High-Prevalence Regions and Explanations<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">The regions exhibiting the highest prevalence of opiate use—primarily opium, heroin, and morphine—are concentrated in South-West Asia, the Near and Middle East, and South Asia, where annual prevalence rates among adults aged 15-64 average around 1.8% in the former areas, with specific locales surpassing 2%. This pattern aligns closely with the geography of the Golden Crescent, encompassing major poppy-producing territories in Afghanistan, Pakistan, and Iran, where cultivation volumes historically supplied over 80% of global illicit opium until a sharp 95% production decline in 2023 following enforcement measures. Proximity to these supply hubs fosters high availability, low prices, and cultural familiarity with opium consumption, driving empirical correlations between production intensity and use rates as documented in supply-demand modeling.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4jabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6jabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7"></span>
<span class="mb-4 block break-words text-[1em] leading-7">South Asia sustains the world&#x27;s largest opiate consumer base, with a regional prevalence of 1.1%, attributable to trafficking spillovers from the Golden Crescent and domestic factors like porous borders and historical trade routes. In contrast, South-East Asia near the Golden Triangle—Myanmar, Laos, and Thailand—shows elevated but variable rates tied to localized opium farming for ethnic minority subsistence and heroin processing, though synthetic shifts have moderated traditional opiate dominance. These areas demonstrate causal supply-side dynamics, where cultivation proximity reduces barriers to entry and sustains habitual use patterns unobserved in distal regions.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4kabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6kabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Prevalence remains markedly lower in the Americas and Europe, at approximately 0.3-0.5%, reflecting greater distances from natural opiate production and a pivot toward synthetic opioids like fentanyl, which inflate absolute user counts without elevating traditional opiate shares. African data is sparse due to surveillance gaps, yet East African ports along southwest Asian heroin conduits report emerging hotspots, suggesting trafficking pathways as a vector for rising use amid weak interdiction. UNODC analyses confirm that deviations from global averages of 0.6% for opiates stem predominantly from geographic adjacency to the Golden Crescent and Triangle, emphasizing production-access linkages over isolated demand factors in explaining regional disparities.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4kqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6kqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<h2 id="country-specific-prevalence-data" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Country-Specific Prevalence Data<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="highest-prevalence-countries" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Highest Prevalence Countries<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Iran exhibits one of the highest rates of opiate use prevalence worldwide, with estimates ranging from 2.3% to 3.3% of the population aged 15-64 reporting past-year use in data spanning 2015-2021.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4mabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[34]</sup> This elevated level stems partly from its position as a primary transit corridor for opiates originating from neighboring Afghanistan, facilitating domestic availability and consumption, including traditional opium use.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8mabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[35]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Afghanistan follows closely, with a reported opiate use prevalence of 2.65% among the 15-64 age group, based on UNODC assessments incorporating national surveys.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4mqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[36]</sup> Historical practices such as opium chewing, combined with the country&#x27;s dominant role in global illicit opium production—accounting for over 80% in recent years—contribute to sustained high domestic consumption despite enforcement efforts.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8mqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[37]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Seychelles and Egypt represent additional empirical outliers, with opiate prevalence estimates around 1.7% to 2.3% in comparable periods, exceeding the global average of approximately 0.6%. In Seychelles, heroin dependence affects roughly 10% of the adult population, indicative of broader opiate involvement amplified by limited resources and trafficking routes through Indian Ocean ports.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4nabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[38]</sup> Egypt&#x27;s figures reflect regional patterns in North Africa, influenced by proximity to production and underreporting in surveys. While percentage-based prevalence highlights these nations, absolute numbers of users are notably larger in populous countries like Pakistan and India due to scale, despite their moderate per-capita rates.</span>
<h3 id="lowest-prevalence-countries" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Lowest Prevalence Countries<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Countries in East Asia, including Japan and the Republic of Korea, report annual opiate use prevalence rates below 0.1% among the population aged 15-64, reflecting rigorous drug control measures and limited domestic production or trafficking routes for opiates.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4oabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[39]</sup> National surveys in Japan from 2023 indicate negligible opiate involvement in overall drug use patterns, with methamphetamine and cannabis dominating reported cases instead.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8oabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[40]</sup> Similarly, South Korea&#x27;s enforcement-focused policies, including mandatory treatment and severe penalties, contribute to sustained low opiate indicators, with past-year use estimates remaining under detectable thresholds in household surveys up to 2022.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Many African nations exhibit minimal reported opiate prevalence, often below 0.2%, as evidenced by limited national surveys and UNODC estimates for sub-Saharan regions where cannabis and other substances predominate over opiates.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4oqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup> For instance, countries like Nigeria show low opiate-specific use rates amid broader drug patterns, corroborated by low treatment demand data from 2021 surveys.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8oqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[41]</sup> These figures align with sparse seizure reports and hospital admissions for opiate-related issues, indicating genuine low exposure rather than solely data gaps.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_coqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[42]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In Western and Central Europe, excluding outliers like the United Kingdom and Ireland, opiate prevalence typically falls below 0.2% based on 2020-2023 data from multiple OECD nations, with countries such as Germany, France, and Italy reporting rates under 0.5% for past-year opioid use.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4pabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[43]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6pabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[19]</sup> This pattern holds across harmonized European Monitoring Centre for Drugs and Drug Addiction indicators, where opiate use remains stable at low levels outside high-problematic-use pockets.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_apabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup> Low prevalence correlates with effective border controls and reduced heroin purity in these areas since the mid-2010s.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_epabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[10]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Verification through indirect metrics, such as treatment entries and drug-induced mortality under 1 per 100,000 in these low-prevalence countries, supports the estimates despite potential underreporting in strict enforcement contexts.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4pqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[18]</sup> UNODC data from 2022-2024 consistently highlight these nations as exemplars of variability, where policy stringency appears linked to suppressed use rates.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8pqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[44]</sup></span>
<h3 id="full-ranked-list" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Full Ranked List<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">The availability of comparable, recent data on opiate use prevalence remains limited, with UNODC relying on a combination of national household surveys, treatment data multipliers, and expert estimates for many countries; direct surveys are rare outside high-prevalence regions near opium production areas. The table below ranks countries with verifiable estimates from the past decade (post-2015), primarily drawn from UNODC datasets, sorted by descending annual prevalence rate among the population aged 15-64. Estimates denote past-year use of opiates (primarily heroin and opium, excluding synthetic opioids unless specified). Over 100 countries lack such recent figures, often due to underreporting in low-detection environments or absence of standardized surveys.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4qqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[44]</sup></span>















































<div class="border-border-l1 overflow-x-auto rounded-lg border my-6 w-full"><table node="[object Object]" class="w-full border-collapse text-sm"><thead node="[object Object]" class="border-border-l1 border-b bg-surface-l1"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Country</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Prevalence (%)</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Year</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Notes/Source</span></th></tr></thead><tbody node="[object Object]" class="divide-border-l1 divide-y"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Iran</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">2.8</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">2021</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">National estimate; high due to proximity to Afghanistan. UNODC World Drug Report 2023.</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_18crabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Afghanistan</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">2.4</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">2015</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Survey-based; includes opium and heroin. UNODC estimates.70299-2/fulltext)</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Pakistan</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">1.0</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">2017</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Regional multiplier model. UNODC data portal.</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_18srabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[45]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Uzbekistan</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.93</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">2015</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">National survey. UNODC.</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_194rabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[46]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Malaysia</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.94</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">2017</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Treatment and seizure-adjusted estimate. UNODC.</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_19crabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[46]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Mauritius</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.91</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">2017</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Household survey. UNODC regional data.</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_19krabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[47]</sup></td></tr></tbody></table></div>
<span class="mb-4 block break-words text-[1em] leading-7">Data gaps persist for most nations, with global opiate prevalence averaging 0.6% in 2021 per UNODC, but country-level figures often extrapolated rather than surveyed.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4rqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup> For restrictive regimes or low-use areas, estimates may understate true rates due to stigma and weak reporting systems.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8rqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[8]</sup></span>
<h2 id="correlates-and-causal-factors" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Correlates and Causal Factors<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="socioeconomic-and-geographic-influences" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Socioeconomic and Geographic Influences<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">
Opiate use prevalence exhibits a strong geographic pattern tied to proximity to primary production centers, particularly in South-West Asia where Afghanistan dominates global illicit opium output. In 2022, Afghanistan accounted for 80% of worldwide illicit opium production, estimated at 6,200 tonnes out of 7,800 tonnes total, facilitating spillover into adjacent transit and consumption markets.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6tabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[48]</sup> This adjacency correlates with elevated regional prevalence rates, such as in the Near and Middle East/South-West Asia subregion, where opiate use remains among the highest globally due to easier access via smuggling routes.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Socioeconomic factors show an inverse association with opiate use, with higher prevalence observed in low-income countries serving as transit hubs. Analysis across Asian nations indicates a negative correlation between opiate abuse rates and GDP per capita (r = -0.31, p = 0.055), suggesting that economic disadvantage in production-adjacent states amplifies vulnerability through limited resources for prevention and treatment.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4tqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[49]</sup> However, while datasets consistently reveal this pattern in low-GDP transit economies like those in Central Asia and the Middle East, direct causation from poverty alone lacks empirical proof, as confounding geographic and supply factors dominate observed trends.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Urbanization and population displacement further exacerbate prevalence as amplifiers of exposure. UNODC data highlights how rapid urban growth and migration flows increase drug availability in densely populated areas, with irregular migrants showing drug use rates up to 61.3%, often involving opiates amid transit stresses.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4uabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[50]</sup> In conflict-affected zones, empirical evidence points to 2-3 times higher opiate use rates compared to stable regions, driven by trauma, disrupted social structures, and opportunistic trafficking, though these patterns hold across multiple datasets without isolating socioeconomic drivers from violence itself.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8uabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[51]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_auabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[52]</sup></span>
<h3 id="drug-policy-enforcement-effects" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Drug Policy Enforcement Effects<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Countries implementing rigorous drug enforcement, particularly supply-side interdiction and severe penalties for possession and trafficking, demonstrate correlations with markedly lower opiate prevalence rates. In Singapore, where possession of small amounts can result in mandatory rehabilitation or imprisonment and trafficking carries the death penalty, annual opiate use prevalence remains below 0.1%, with urine testing and strict border controls contributing to sustained low levels reported in national surveys.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4vabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[53]</sup> Similarly, Japan&#x27;s comprehensive narcotics laws, emphasizing zero tolerance and high conviction rates, align with opiate use rates under 0.1% in the general population, as evidenced by nationwide surveys showing minimal illicit opioid involvement compared to other substances.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8vabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[54]</sup> These Asian examples contrast with higher prevalence in contexts of lax enforcement or state fragility, such as Afghanistan, where opiate use exceeds 2.5% amid limited central control over production and trafficking routes.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cvabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">United Nations Office on Drugs and Crime (UNODC) analyses indicate that effective enforcement disrupts supply chains, reducing availability and thereby curbing use, particularly for supply-driven opiates like heroin. Global seizure data from UNODC reports show inverse patterns: regions with intensified interdiction, such as parts of East Asia, experience depressed prevalence following spikes in opium and heroin seizures, suggesting causal links through diminished street-level access rather than demand-side factors alone.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4vqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[16]</sup> In Iran, border fortifications and aggressive anti-trafficking operations post-2000, including mass executions for major traffickers, coincided with temporary dips in domestic prevalence from peaks above 3% in the 1990s to around 2.1% by the 2010s, though proximity to Afghan supply limits full eradication.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8vqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[55]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Conversely, the United States illustrates how permissive legal supply channels can elevate prevalence despite parallel illicit enforcement efforts. The opioid crisis escalated in the 2010s with prescription rates surging to over 250 million annually by 2012, driving non-medical use prevalence to 1.5% for opioids excluding heroin, as lax regulatory oversight on pharmaceutical distribution outpaced interdiction impacts.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_50abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[56]</sup> Subsequent prescription curbs post-2016 correlated with declines in prescription-related overdoses by 33%, underscoring enforcement&#x27;s role in constraining supply vectors, though synthetic shifts like fentanyl sustained high overall use.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_90abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> These patterns affirm that prevalence more closely tracks interdiction efficacy and supply controls than isolated education or treatment initiatives.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d0abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[57]</sup></span>
<h2 id="debates-on-data-interpretation" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Debates on Data Interpretation<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="reliability-of-estimates-in-restrictive-regimes" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Reliability of Estimates in Restrictive Regimes<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">In countries characterized by stringent drug prohibition and limited civil liberties, such as China and Saudi Arabia, official estimates of opiate prevalence often register at or near zero, with China&#x27;s registered drug users numbering approximately 2.4 million in 2021 (predominantly methamphetamine rather than opiates) out of a population exceeding 1.4 billion, implying an opiate-specific rate below 0.1%.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_51qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[58]</sup> These figures derive from government-monitored registration systems enforced under severe penalties, including execution for trafficking, which incentivize non-disclosure and raise questions of systematic undercounting.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_91qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[59]</sup> Triangulation with indirect indicators, such as border seizures and treatment admissions, reveals potential gaps; for instance, early 2000s analyses estimated China&#x27;s actual opiate addict population at several times the registered 1.14 million, though recent data show stabilization at low levels.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d1qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[59]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Independent verification methods, including wastewater-based epidemiology, offer a counterpoint to self-reported or registered data, detecting biomarkers of opiate metabolites in sewage to estimate community consumption objectively. In China, nationwide expansion of such monitoring since 2018 has documented significant declines in heroin and other opiate residues, aligning with official reports of reduced use amid aggressive interdiction campaigns, rather than indicating concealed epidemics.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_52abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[60]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_72abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[58]</sup> Similarly, in Saudi Arabia, where opiate prevalence is reported at under 0.1% through national surveys under Sharia-influenced prohibitions, limited wastewater and forensic studies corroborate low population-level exposure, though subgroup analyses (e.g., among youth) detect sporadic misuse not captured in aggregates.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_b2abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[61]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d2abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[62]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Comparisons with liberal democracies highlight discrepancies: the United States, with self-reported opiate use disorder rates around 1-2% via anonymous surveys, contrasts sharply with restrictive regimes&#x27; figures, but this gap persists even after adjusting for methodological differences, as evidenced by cross-national validations showing enforcement correlates with lower biomarker-detected consumption. Claims of pervasive underreporting in authoritarian contexts—often advanced in academic critiques assuming equivalence to open-society stigma—overstate distortions, as empirical proxies like wastewater yield consistent low signals where penalties deter supply and demand effectively, prioritizing causal enforcement impacts over unsubstantiated concealment narratives.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_52qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[63]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_72qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[60]</sup></span>
<h3 id="policy-efficacy-versus-reported-prevalence" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Policy Efficacy Versus Reported Prevalence<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Proponents of stringent drug enforcement policies cite empirical correlations between harsh penalties and reduced opiate use prevalence, as observed in jurisdictions like Singapore, where lifetime illicit drug consumption rates remain among the lowest globally at approximately 3-5% of the adult population, with opiate-specific abuse estimated at 30 per 100,000 people compared to 600 in the United States.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_53qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[64]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_73qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[65]</sup> Singapore&#x27;s framework, including mandatory rehabilitation and capital punishment for trafficking, has sustained these low figures since the 1970s, contrasting with higher-use environments and supporting causal claims that deterrence curbs initiation and sustained use.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_b3qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[66]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In contrast, Portugal&#x27;s 2001 decriminalization, often lauded by harm reduction advocates for slashing HIV infections and overdose deaths by over 80% in the ensuing decade, coincided with stable or modestly declining lifetime opiate prevalence rates across age groups, yet high-risk opioid users per capita exceeded the European average as of 2015, with estimates around 33,000 individuals.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_54abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[67]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_74abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[68]</sup> Critics of punitive approaches, drawing from academic and NGO sources, contend that low reported prevalence in enforcement-heavy systems masks underground use and unaddressed harms, potentially inflating black-market risks; however, opiate-specific metrics, including treatment uptake and overdose incidence, do not consistently validate this for strict regimes, where both prevalence and fatalities remain subdued absent widespread harm reduction infrastructure.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_b4abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[69]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The United Nations Office on Drugs and Crime&#x27;s 2025 World Drug Report underscores that global instability—encompassing conflicts, economic disruptions, and trafficking adaptations—elevates opiate consumption irrespective of policy stringency, with record-high use affecting 6% of the global population amid synthetic opioid surges.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_54qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[15]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_74qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[17]</sup> This highlights the limits of attributing prevalence solely to enforcement efficacy, as supply proximity and socioeconomic pressures exert stronger causal influences; nonetheless, cross-national data prioritize verifiable prevalence reductions in high-enforcement contexts over interpretive claims from ideologically aligned sources, which often underemphasize deterrence&#x27;s role in empirical outcomes.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_b4qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[16]</sup> Such analyses reveal punitive policies&#x27; comparative success in constraining use where implementable, though not as panacea against exogenous drivers.</span></article><div id="references" class="min-w-0 scroll-mt-8 overflow-hidden"><div class="text-[16px]"><h2 id="references" node="[object Object]" class="mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden">References</h2></div><ol class="columns-1 gap-x-12 [counter-reset:item] md:columns-2"><li id="https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2024.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2024.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2024.html</a></span></div></li><li id="https://dataunodc.un.org/dp-drug-use-prevalence" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://dataunodc.un.org/dp-drug-use-prevalence" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://dataunodc.un.org/dp-drug-use-prevalence</a></span></div></li><li id="https://www.euda.europa.eu/publications/eu-drug-markets/heroin-and-other-opioids/global-context_en" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.euda.europa.eu/publications/eu-drug-markets/heroin-and-other-opioids/global-context_en" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.euda.europa.eu/publications/eu-drug-markets/heroin-and-other-opioids/global-context_en</a></span></div></li><li id="https://wdr.unodc.org/wdr2020/field/WDR20_Booklet_2.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://wdr.unodc.org/wdr2020/field/WDR20_Booklet_2.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://wdr.unodc.org/wdr2020/field/WDR20_Booklet_2.pdf</a></span></div></li><li id="https://www.unodc.org/unodc/frontpage/2022/August/baking_-a-possible-pathway-out-of-drug-use-for-women-in-kerman--iran.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.unodc.org/unodc/frontpage/2022/August/baking_-a-possible-pathway-out-of-drug-use-for-women-in-kerman--iran.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.unodc.org/unodc/frontpage/2022/August/baking_-a-possible-pathway-out-of-drug-use-for-women-in-kerman--iran.html</a></span></div></li><li id="https://dataunodc.un.org/sites/dataunodc.un.org/files/metadata_drug_use_and_treatment.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://dataunodc.un.org/sites/dataunodc.un.org/files/metadata_drug_use_and_treatment.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://dataunodc.un.org/sites/dataunodc.un.org/files/metadata_drug_use_and_treatment.pdf</a></span></div></li><li id="https://www.unodc.org/documents/scientific/Terminology_English.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.unodc.org/documents/scientific/Terminology_English.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.unodc.org/documents/scientific/Terminology_English.pdf</a></span></div></li><li id="https://www.unodc.org/unodc/data-and-analysis/world-drug-report-2023.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.unodc.org/unodc/data-and-analysis/world-drug-report-2023.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.unodc.org/unodc/data-and-analysis/world-drug-report-2023.html</a></span></div></li><li id="https://www.unodc.org/res/WDR-2023/WDR23_Exsum_fin_DP.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.unodc.org/res/WDR-2023/WDR23_Exsum_fin_DP.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.unodc.org/res/WDR-2023/WDR23_Exsum_fin_DP.pdf</a></span></div></li><li id="https://www.unodc.org/documents/data-and-analysis/WDR_2024/WDR24_Key_findings_and_conclusions.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.unodc.org/documents/data-and-analysis/WDR_2024/WDR24_Key_findings_and_conclusions.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.unodc.org/documents/data-and-analysis/WDR_2024/WDR24_Key_findings_and_conclusions.pdf</a></span></div></li><li id="https://www.unodc.org/documents/scientific/Global_SMART_21_web_new.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.unodc.org/documents/scientific/Global_SMART_21_web_new.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.unodc.org/documents/scientific/Global_SMART_21_web_new.pdf</a></span></div></li><li id="https://www.aidsdatahub.org/resource/unodc-world-drug-report-2023" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.aidsdatahub.org/resource/unodc-world-drug-report-2023" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.aidsdatahub.org/resource/unodc-world-drug-report-2023</a></span></div></li><li id="https://www.unodc.org/res/wdr2022/MS/WDR22_Booklet_2.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.unodc.org/res/wdr2022/MS/WDR22_Booklet_2.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.unodc.org/res/wdr2022/MS/WDR22_Booklet_2.pdf</a></span></div></li><li id="https://www.unodc.org/documents/data-and-analysis/WDR_2025/Annex/WDR2025_Methodological_Annex.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.unodc.org/documents/data-and-analysis/WDR_2025/Annex/WDR2025_Methodological_Annex.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.unodc.org/documents/data-and-analysis/WDR_2025/Annex/WDR2025_Methodological_Annex.pdf</a></span></div></li><li id="https://www.unodc.org/unodc/data-and-analysis/world-drug-report-2025.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.unodc.org/unodc/data-and-analysis/world-drug-report-2025.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.unodc.org/unodc/data-and-analysis/world-drug-report-2025.html</a></span></div></li><li id="https://www.unodc.org/documents/data-and-analysis/WDR_2025/WDR25_B1_Key_findings.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.unodc.org/documents/data-and-analysis/WDR_2025/WDR25_B1_Key_findings.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.unodc.org/documents/data-and-analysis/WDR_2025/WDR25_B1_Key_findings.pdf</a></span></div></li><li id="https://unis.unvienna.org/unis/en/pressrels/2025/unisnar1499.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://unis.unvienna.org/unis/en/pressrels/2025/unisnar1499.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://unis.unvienna.org/unis/en/pressrels/2025/unisnar1499.html</a></span></div></li><li id="https://www.who.int/news-room/fact-sheets/detail/opioid-overdose" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.who.int/news-room/fact-sheets/detail/opioid-overdose" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.who.int/news-room/fact-sheets/detail/opioid-overdose</a></span></div></li><li id="https://www.euda.europa.eu/publications/european-drug-report/2024_en" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.euda.europa.eu/publications/european-drug-report/2024_en" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.euda.europa.eu/publications/european-drug-report/2024_en</a></span></div></li><li id="https://www.unodc.org/arq/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.unodc.org/arq/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.unodc.org/arq/</a></span></div></li><li id="https://www.unodc.org/documents/ARQ/ARQ_Guidelines.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.unodc.org/documents/ARQ/ARQ_Guidelines.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.unodc.org/documents/ARQ/ARQ_Guidelines.pdf</a></span></div></li><li id="https://wdr.unodc.org/wdr2019/prelaunch/WDR-2019-Methodology-FINAL.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://wdr.unodc.org/wdr2019/prelaunch/WDR-2019-Methodology-FINAL.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://wdr.unodc.org/wdr2019/prelaunch/WDR-2019-Methodology-FINAL.pdf</a></span></div></li><li id="https://www.unodc.org/pdf/gap_toolkit_module2.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.unodc.org/pdf/gap_toolkit_module2.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.unodc.org/pdf/gap_toolkit_module2.pdf</a></span></div></li><li id="https://www.unodc.org/res/wdr2022/MS/Statistical%2520Annex/WDR-2022-Methodology_final.docx" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.unodc.org/res/wdr2022/MS/Statistical%2520Annex/WDR-2022-Methodology_final.docx" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.unodc.org/res/wdr2022/MS/Statistical%2520Annex/WDR-2022-Methodology_final.docx</a></span></div></li><li id="https://www.sciencedirect.com/science/article/abs/pii/S1047279721003549" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/abs/pii/S1047279721003549" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/abs/pii/S1047279721003549</a></span></div></li><li id="https://substanceabusepolicy.biomedcentral.com/articles/10.1186/s13011-021-00398-3" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://substanceabusepolicy.biomedcentral.com/articles/10.1186/s13011-021-00398-3" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://substanceabusepolicy.biomedcentral.com/articles/10.1186/s13011-021-00398-3</a></span></div></li><li id="https://www.aic.gov.au/publications/tandi/tandi260" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.aic.gov.au/publications/tandi/tandi260" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.aic.gov.au/publications/tandi/tandi260</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC4713294/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4713294/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC4713294/</a></span></div></li><li id="https://journals.sagepub.com/doi/10.1177/002204269502500107" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://journals.sagepub.com/doi/10.1177/002204269502500107" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://journals.sagepub.com/doi/10.1177/002204269502500107</a></span></div></li><li id="https://academic.oup.com/aje/article-pdf/149/10/955/413434/149-10-955.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://academic.oup.com/aje/article-pdf/149/10/955/413434/149-10-955.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://academic.oup.com/aje/article-pdf/149/10/955/413434/149-10-955.pdf</a></span></div></li><li id="https://www.consilium.europa.eu/en/policies/opioids-drugs-heroin/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.consilium.europa.eu/en/policies/opioids-drugs-heroin/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.consilium.europa.eu/en/policies/opioids-drugs-heroin/</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S0034837625001408" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S0034837625001408" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S0034837625001408</a></span></div></li><li id="https://www.issup.net/knowledge-share/resources/2024-08/2024-unodc-world-drug-report-highlights-brief-reflections-0" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.issup.net/knowledge-share/resources/2024-08/2024-unodc-world-drug-report-highlights-brief-reflections-0" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.issup.net/knowledge-share/resources/2024-08/2024-unodc-world-drug-report-highlights-brief-reflections-0</a></span></div></li><li id="https://www.unodc.org/islamicrepublicofiran/en/unodc-iran-supports-improving-health-conditions-of-inmates.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.unodc.org/islamicrepublicofiran/en/unodc-iran-supports-improving-health-conditions-of-inmates.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.unodc.org/islamicrepublicofiran/en/unodc-iran-supports-improving-health-conditions-of-inmates.html</a></span></div></li><li id="https://www.unodc.org/documents/wdr/WDR_2010/1.2_The_global_heroin_market.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.unodc.org/documents/wdr/WDR_2010/1.2_The_global_heroin_market.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.unodc.org/documents/wdr/WDR_2010/1.2_The_global_heroin_market.pdf</a></span></div></li><li id="https://www.apu.ac.jp/rcaps/uploads/fckeditor/publications/journal/RJAPS34_9_Haidary.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.apu.ac.jp/rcaps/uploads/fckeditor/publications/journal/RJAPS34_9_Haidary.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.apu.ac.jp/rcaps/uploads/fckeditor/publications/journal/RJAPS34_9_Haidary.pdf</a></span></div></li><li id="https://www.unodc.org/documents/crop-monitoring/Afghanistan/Afghanistan_opium_survey_2023.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.unodc.org/documents/crop-monitoring/Afghanistan/Afghanistan_opium_survey_2023.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.unodc.org/documents/crop-monitoring/Afghanistan/Afghanistan_opium_survey_2023.pdf</a></span></div></li><li id="https://www.bbc.com/news/world-africa-64785171" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.bbc.com/news/world-africa-64785171" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.bbc.com/news/world-africa-64785171</a></span></div></li><li id="https://www.unodc.org/roseap/uploads/documents/Publications/2024/Synthetic_Drugs_in_East_and_Southeast_Asia_2024.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.unodc.org/roseap/uploads/documents/Publications/2024/Synthetic_Drugs_in_East_and_Southeast_Asia_2024.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.unodc.org/roseap/uploads/documents/Publications/2024/Synthetic_Drugs_in_East_and_Southeast_Asia_2024.pdf</a></span></div></li><li id="https://www.unodc.org/roseap/uploads/documents/Publications/2025/Synthetic_Drugs_in_East_and_Southeast_Asia_2025.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.unodc.org/roseap/uploads/documents/Publications/2025/Synthetic_Drugs_in_East_and_Southeast_Asia_2025.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.unodc.org/roseap/uploads/documents/Publications/2025/Synthetic_Drugs_in_East_and_Southeast_Asia_2025.pdf</a></span></div></li><li id="https://www.eeas.europa.eu/node/57381_fr" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.eeas.europa.eu/node/57381_fr" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.eeas.europa.eu/node/57381_fr</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC7269163/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7269163/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC7269163/</a></span></div></li><li id="https://www.oecd.org/en/publications/2023/11/health-at-a-glance-2023_e04f8239/full-report/illicit-drug-use_ac094ca7.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.oecd.org/en/publications/2023/11/health-at-a-glance-2023_e04f8239/full-report/illicit-drug-use_ac094ca7.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.oecd.org/en/publications/2023/11/health-at-a-glance-2023_e04f8239/full-report/illicit-drug-use_ac094ca7.html</a></span></div></li><li id="https://www.unodc.org/unodc/data-and-analysis/world-drug-report-2024.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.unodc.org/unodc/data-and-analysis/world-drug-report-2024.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.unodc.org/unodc/data-and-analysis/world-drug-report-2024.html</a></span></div></li><li id="https://dataunodc.un.org/content/country-profile" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://dataunodc.un.org/content/country-profile" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://dataunodc.un.org/content/country-profile</a></span></div></li><li id="https://dataunodc.un.org/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://dataunodc.un.org/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://dataunodc.un.org/</a></span></div></li><li id="https://dataunodc.un.org/content/country-list" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://dataunodc.un.org/content/country-list" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://dataunodc.un.org/content/country-list</a></span></div></li><li id="https://www.euda.europa.eu/publications/eu-drug-markets/heroin-and-other-opioids/production_en" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.euda.europa.eu/publications/eu-drug-markets/heroin-and-other-opioids/production_en" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.euda.europa.eu/publications/eu-drug-markets/heroin-and-other-opioids/production_en</a></span></div></li><li id="https://www.sop.org.tw/sop_journal/pastIssues/info_PdfFiles.asp?/1475.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sop.org.tw/sop_journal/pastIssues/info_PdfFiles.asp?/1475.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sop.org.tw/sop_journal/pastIssues/info_PdfFiles.asp?/1475.html</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC8352205/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8352205/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC8352205/</a></span></div></li><li id="https://conflictandhealth.biomedcentral.com/articles/10.1186/s13031-021-00407-z" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://conflictandhealth.biomedcentral.com/articles/10.1186/s13031-021-00407-z" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://conflictandhealth.biomedcentral.com/articles/10.1186/s13031-021-00407-z</a></span></div></li><li id="https://www.unodc.org/documents/data-and-analysis/WDR_2025/WDR25_Special_points_of_interest.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.unodc.org/documents/data-and-analysis/WDR_2025/WDR25_Special_points_of_interest.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.unodc.org/documents/data-and-analysis/WDR_2025/WDR25_Special_points_of_interest.pdf</a></span></div></li><li id="https://www.cnb.gov.sg/docs/default-source/drug-situation-report-documents/cnb-annual-statistics-2023.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.cnb.gov.sg/docs/default-source/drug-situation-report-documents/cnb-annual-statistics-2023.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.cnb.gov.sg/docs/default-source/drug-situation-report-documents/cnb-annual-statistics-2023.pdf</a></span></div></li><li id="https://www.ncnp.go.jp/nimh/yakubutsu/report/pdf/2017_0522_2015EN_shimane2_k.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncnp.go.jp/nimh/yakubutsu/report/pdf/2017_0522_2015EN_shimane2_k.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncnp.go.jp/nimh/yakubutsu/report/pdf/2017_0522_2015EN_shimane2_k.pdf</a></span></div></li><li id="https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-022-00719-0" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-022-00719-0" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-022-00719-0</a></span></div></li><li id="https://www.cdc.gov/overdose-prevention/about/understanding-the-opioid-overdose-epidemic.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.cdc.gov/overdose-prevention/about/understanding-the-opioid-overdose-epidemic.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.cdc.gov/overdose-prevention/about/understanding-the-opioid-overdose-epidemic.html</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC3787412/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3787412/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC3787412/</a></span></div></li><li id="http://losangeles.china-consulate.gov.cn/eng/topnews/202306/t20230628_11104750.htm" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="http://losangeles.china-consulate.gov.cn/eng/topnews/202306/t20230628_11104750.htm" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">http://losangeles.china-consulate.gov.cn/eng/topnews/202306/t20230628_11104750.htm</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/16669899/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/16669899/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/16669899/</a></span></div></li><li id="https://www.nature.com/articles/d41586-018-05728-3" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nature.com/articles/d41586-018-05728-3" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nature.com/articles/d41586-018-05728-3</a></span></div></li><li id="https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-024-21190-5" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-024-21190-5" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-024-21190-5</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC10491761/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10491761/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC10491761/</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S0043135421009830" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S0043135421009830" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S0043135421009830</a></span></div></li><li id="https://annals.edu.sg/prevalence-of-consumption-of-illicit-drugs-and-associated-factors-from-a-nationwide-epidemiological-survey-the-singapore-health-and-lifestyle-survey/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://annals.edu.sg/prevalence-of-consumption-of-illicit-drugs-and-associated-factors-from-a-nationwide-epidemiological-survey-the-singapore-health-and-lifestyle-survey/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://annals.edu.sg/prevalence-of-consumption-of-illicit-drugs-and-associated-factors-from-a-nationwide-epidemiological-survey-the-singapore-health-and-lifestyle-survey/</a></span></div></li><li id="https://www.washingtonpost.com/opinions/singapore-is-winning-the-war-on-drugs-heres-how/2018/03/11/b8c25278-22e9-11e8-946c-9420060cb7bd_story.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.washingtonpost.com/opinions/singapore-is-winning-the-war-on-drugs-heres-how/2018/03/11/b8c25278-22e9-11e8-946c-9420060cb7bd_story.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.washingtonpost.com/opinions/singapore-is-winning-the-war-on-drugs-heres-how/2018/03/11/b8c25278-22e9-11e8-946c-9420060cb7bd_story.html</a></span></div></li><li id="https://www.unodc.org/documents/data-and-analysis/Studies/100_Years_of_Drug_Control.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.unodc.org/documents/data-and-analysis/Studies/100_Years_of_Drug_Control.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.unodc.org/documents/data-and-analysis/Studies/100_Years_of_Drug_Control.pdf</a></span></div></li><li id="https://ftp.iza.org/dp10895.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://ftp.iza.org/dp10895.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://ftp.iza.org/dp10895.pdf</a></span></div></li><li id="https://transformdrugs.org/blog/drug-decriminalisation-in-portugal-setting-the-record-straight" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://transformdrugs.org/blog/drug-decriminalisation-in-portugal-setting-the-record-straight" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://transformdrugs.org/blog/drug-decriminalisation-in-portugal-setting-the-record-straight</a></span></div></li><li id="https://obamawhitehouse.archives.gov/sites/default/files/ondcp/Fact_Sheets/portugal_fact_sheet_8-25-10.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://obamawhitehouse.archives.gov/sites/default/files/ondcp/Fact_Sheets/portugal_fact_sheet_8-25-10.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://obamawhitehouse.archives.gov/sites/default/files/ondcp/Fact_Sheets/portugal_fact_sheet_8-25-10.pdf</a></span></div></li></ol></div></div></div><div class="hidden min-[1400px]:block"></div></div></div><!--$--><!--/$--><div role="region" aria-label="Notifications (F8)" tabindex="-1" style="pointer-events:none"><ol tabindex="-1" class="pointer-events-none fixed top-0 z-[100] flex max-h-screen w-full flex-col-reverse p-4 max-sm:left-0 sm:bottom-0 sm:right-0 sm:top-auto sm:max-w-[420px] sm:flex-col pl-16 pr-2 pt-16 sm:px-4"></ol></div><script type="application/json" id="server-client-data-experimentation">{"status":"uninitialized"}</script><script src="/_next/static/chunks/webpack-e121ed42680f327e.js" nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx" id="_R_" async=""></script><script nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx">(self.__next_f=self.__next_f||[]).push([0])</script><script nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx">self.__next_f.push([1,"1:\"$Sreact.fragment\"\n3:I[91363,[],\"\"]\n4:I[23775,[],\"\"]\n5:I[57654,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"3699\",\"static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js\"],\"PageHeaderProvider\"]\n6:I[17618,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"3699\",\"static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js\"],\"HeaderContent\"]\n7:I[25529,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"6751\",\"static/chunks/app/page/%5Bslug%5D/not-found-69a3edc7db5749d6.js\"],\"default\"]\n9:I[6666,[],\"OutletBoundary\"]\nb:I[80415,[],\"AsyncMetadataOutlet\"]\nd:I[6666,[],\"ViewportBoundary\"]\nf:I[6666,[],\"MetadataBoundary\"]\n10:\"$Sreact.suspense\"\n12:I[95909,[\"4219\",\"static/chunks/app/global-error-4d07d20223cd4b4c.js\"],\"default\"]\n"])</script><script nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx">self.__next_f.push([1,"13:I[51498,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"ConstantsProvider\"]\n"])</script><script nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx">self.__next_f.push([1,"14:I[91073,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx">self.__next_f.push([1,"15:I[38642,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx">self.__next_f.push([1,"16:I[99648,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"default\"]\n"])</script><script nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx">self.__next_f.push([1,"17:I[78825,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx">self.__next_f.push([1,"18:I[8550,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"MixpanelProvider\"]\n"])</script><script nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx">self.__next_f.push([1,"19:I[12290,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"MobileTocProvider\"]\n"])</script><script nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx">self.__next_f.push([1,"1a:I[53947,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"NuqsAdapter\"]\n"])</script><script nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx">self.__next_f.push([1,"1b:I[91873,[\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8039\",\"static/chunks/app/error-4a29e9399afba038.js\"],\"default\"]\n1c:I[5091,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"4345\",\"static/chunks/app/not-found-dd95690acf732f18.js\"],\"default\"]\n"])</script><script nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx">self.__next_f.push([1,"1d:I[16091,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx">self.__next_f.push([1,":HL[\"/_next/static/media/1f2316909698f815.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/3d4419af2cf8609b.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/4dec29efcaeb336c.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/74452ea3ef0f9101.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/904ef0a86fe32a00.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/d886a03bcda7ad8f.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/e1447589d6f59c4b.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/f5a90156f8995c8c.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/css/62c4caba71dfda84.css\",\"style\",{\"nonce\":\"ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx\"}]\n:HL[\"/_next/static/css/eb3d87f98fe1565f.css\",\"style\",{\"nonce\":\"ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx\"}]\n:HL[\"/_next/static/css/1b5e561215938d4d.css\",\"style\",{\"nonce\":\"ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx\"}]\n:HL[\"/_next/static/css/0227d069a630d414.css\",\"style\",{\"nonce\":\"ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx\"}]\n:HL[\"/_next/static/css/f87fff2ab93d05a7.css\",\"style\",{\"nonce\":\"ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx\"}]\n"])</script><script nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx">self.__next_f.push([1,"0:{\"P\":null,\"b\":\"BpM29AX4fmgcUxZ_6t0le\",\"p\":\"\",\"c\":[\"\",\"page\",\"List_of_countries_by_prevalence_of_opiates_use\"],\"i\":false,\"f\":[[[\"\",{\"children\":[\"page\",{\"children\":[[\"slug\",\"List_of_countries_by_prevalence_of_opiates_use\",\"d\"],{\"children\":[\"__PAGE__\",{}]}]}]},\"$undefined\",\"$undefined\",true],[\"\",[\"$\",\"$1\",\"c\",{\"children\":[[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/62c4caba71dfda84.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx\"}],[\"$\",\"link\",\"1\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/eb3d87f98fe1565f.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx\"}],[\"$\",\"link\",\"2\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/1b5e561215938d4d.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx\"}],[\"$\",\"link\",\"3\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/0227d069a630d414.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx\"}]],\"$L2\"]}],{\"children\":[\"page\",[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":\"$undefined\",\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}],{\"children\":[[\"slug\",\"List_of_countries_by_prevalence_of_opiates_use\",\"d\"],[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L5\",null,{\"children\":[[\"$\",\"$L6\",null,{\"maxWidth\":\"full\",\"mobileOptions\":{\"right\":{\"showFixedIssues\":true,\"showThemeSwitcher\":true,\"showSearch\":true,\"showTableOfContents\":true}}}],[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"$L7\",null,{}],[]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}]]}],{\"children\":[\"__PAGE__\",[\"$\",\"$1\",\"c\",{\"children\":[\"$L8\",[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/f87fff2ab93d05a7.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx\"}]],[\"$\",\"$L9\",null,{\"children\":[\"$La\",[\"$\",\"$Lb\",null,{\"promise\":\"$@c\"}]]}]]}],{},null,false]},null,false]},null,false]},null,false],[\"$\",\"$1\",\"h\",{\"children\":[null,[[\"$\",\"$Ld\",null,{\"children\":\"$Le\"}],[\"$\",\"meta\",null,{\"name\":\"next-size-adjust\",\"content\":\"\"}]],[\"$\",\"$Lf\",null,{\"children\":[\"$\",\"div\",null,{\"hidden\":true,\"children\":[\"$\",\"$10\",null,{\"fallback\":null,\"children\":\"$L11\"}]}]}]]}],false]],\"m\":\"$undefined\",\"G\":[\"$12\",[]],\"s\":false,\"S\":false}\n"])</script><script nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx">self.__next_f.push([1,"2:[\"$\",\"html\",null,{\"lang\":\"en\",\"className\":\"bg-surface-base antialiased\",\"suppressHydrationWarning\":true,\"children\":[[\"$\",\"head\",null,{\"children\":[[\"$\",\"title\",null,{\"children\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"type\":\"image/x-icon\",\"href\":\"/favicon.ico\",\"sizes\":\"48x48\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"href\":\"/images/icon-dark.png\",\"media\":\"(prefers-color-scheme: light)\",\"type\":\"image/png\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"href\":\"/images/icon-light.png\",\"media\":\"(prefers-color-scheme: dark)\",\"type\":\"image/png\"}],[\"$\",\"link\",null,{\"rel\":\"apple-touch-icon\",\"href\":\"/icon-192x192.png\"}],[\"$\",\"link\",null,{\"rel\":\"manifest\",\"href\":\"/manifest.webmanifest\"}],[\"$\",\"meta\",null,{\"name\":\"robots\",\"content\":\"index, follow\"}],[\"$\",\"meta\",null,{\"name\":\"googlebot\",\"content\":\"index, follow, max-snippet:-1\"}],[\"$\",\"meta\",null,{\"property\":\"og:title\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"property\":\"og:description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"meta\",null,{\"property\":\"og:url\",\"content\":\"https://grokipedia.com\"}],[\"$\",\"meta\",null,{\"property\":\"og:site_name\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"property\":\"og:locale\",\"content\":\"en_US\"}],[\"$\",\"meta\",null,{\"property\":\"og:type\",\"content\":\"website\"}],[\"$\",\"meta\",null,{\"property\":\"og:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:width\",\"content\":\"512\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:height\",\"content\":\"512\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:alt\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:card\",\"content\":\"summary\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:creator\",\"content\":\"@Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:title\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}]]}],[\"$\",\"body\",null,{\"className\":\"flex h-[100svh] w-full flex-col __variable_13c637 __variable_8a0ba0 __variable_779740 __variable_2484fd __variable_525cc3 __variable_13486b\",\"children\":[[\"$\",\"$L13\",null,{\"children\":[\"$\",\"$L14\",null,{\"children\":[\"$\",\"$L15\",null,{\"defaultTheme\":\"dark\",\"nonce\":\"ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx\",\"children\":[\"$\",\"$L16\",null,{\"children\":[\"$\",\"$L17\",null,{\"children\":[\"$\",\"$L18\",null,{\"children\":[\"$\",\"$L19\",null,{\"children\":[\"$\",\"$L1a\",null,{\"children\":[[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$1b\",\"errorStyles\":[],\"errorScripts\":[],\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"$L1c\",null,{}],[]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}],[\"$\",\"$L1d\",null,{}]]}]}]}]}]}]}]}]}],[\"$\",\"script\",null,{\"type\":\"application/json\",\"id\":\"server-client-data-experimentation\",\"children\":\"{\\\"status\\\":\\\"uninitialized\\\"}\"}]]}]]}]\n"])</script><script nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx">self.__next_f.push([1,"e:[[\"$\",\"meta\",\"0\",{\"charSet\":\"utf-8\"}],[\"$\",\"meta\",\"1\",{\"name\":\"viewport\",\"content\":\"width=device-width, initial-scale=1, interactive-widget=resizes-content\"}]]\na:null\n"])</script><script nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx">self.__next_f.push([1,"1e:I[42712,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"HydrationBoundary\"]\n"])</script><script nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx">self.__next_f.push([1,"21:I[6367,[],\"IconMark\"]\n1f:Tabe9,"])</script><script nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx">self.__next_f.push([1,"# List of countries by prevalence of opiates use\n\n![Flag of Iran](./_assets_/Flag_of_Iran.svg.png)\nThe list of countries by prevalence of opiates use ranks nations based on the estimated annual prevalence rate of opiate consumption—encompassing substances like heroin, opium, and morphine—among the population aged 15–64, as compiled from national surveys, treatment records, and indirect indicators by the United Nations Office on Drugs and Crime (UNODC).[](https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2024.html) These figures reflect past-year use and serve as a metric for assessing the scale of illicit opiate involvement relative to population size, highlighting geographic and socioeconomic patterns tied to production, transit, and demand.[](https://dataunodc.un.org/dp-drug-use-prevalence)\n\nGlobally, opiate use affects approximately 31.5 million people, equating to a prevalence of about 0.6% of the adult population, with the vast majority of users concentrated in Asia due to proximity to primary production areas in Afghanistan and Myanmar.[](https://www.euda.europa.eu/publications/eu-drug-markets/heroin-and-other-opioids/global-context_en) Regional disparities are pronounced, with South Asia exhibiting a 1.1% prevalence—nearly double the worldwide average—and South-West Asia even higher at around 1.8%, driven by opium cultivation in the Golden Crescent and trafficking corridors.[](https://www.euda.europa.eu/publications/eu-drug-markets/heroin-and-other-opioids/global-context_en)[](https://wdr.unodc.org/wdr2020/field/WDR20_Booklet_2.pdf) Countries such as Iran, Pakistan, and those in Central Asia consistently rank among the highest, where factors including porous borders, economic hardship, and historical consumption patterns exacerbate use rates exceeding 1–2% in some estimates.[](https://www.unodc.org/unodc/frontpage/2022/August/baking_-a-possible-pathway-out-of-drug-use-for-women-in-kerman--iran.html)\n\nThe rankings underscore causal linkages between opiate prevalence and upstream supply dynamics, as nations adjacent to cultivation zones face elevated exposure through smuggling routes and local diversion, contrasting with lower rates in distant regions despite global distribution efforts by traffickers.[](https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2024.html) Data reliability varies, with self-reported surveys prone to underestimation in stigmatized contexts and limited coverage in low-resource settings, yet UNODC's aggregation provides the most systematic global benchmark.[](https://dataunodc.un.org/sites/dataunodc.un.org/files/metadata_drug_use_and_treatment.pdf) This list informs policy by revealing that prevalence correlates more strongly with regional production hotspots than with demand-side interventions alone, challenging narratives that overemphasize isolated epidemics in high-income countries while regional data points to persistent supply-driven challenges in Asia.\n\n## Definitions and Measurement\n\n### Scope of Opiates and Exclusions\n\nOpiates are defined as naturally occurring alkaloids extracted from the opium poppy *Papaver somniferum*, primarily including morphine, codeine, thebaine, and their semisynthetic derivatives such as heroin and oxycodone.[](https://www.unodc.org/documents/scientific/Terminology_English.pdf) This narrow scope excludes fully synthetic opioids, which mimic opiate effects through opioid receptor binding but lack natural derivation, such as fentanyl, methadone, tramadol, and pethidine.[](https://www.unodc.org/documents/scientific/Terminology_English.pdf) While media and public discourse frequently conflate opiates with the broader opioid category—encompassing both natural and synthetic substances—United Nations Office on Drugs and Crime (UNODC) monitoring distinguishes them to isolate trafficking and use patterns tied to opium production.[](https://www.unodc.org/unodc/data-and-analysis/world-drug-report-2023.html)\n\nPrevalence statistics for opiates emphasize illicit or non-medical use, defined as consumption without medical authorization or for purposes beyond prescribed therapeutic intent, often measured via past-year use indicators in population surveys.[](https://www.unodc.org/res/WDR-2023/WDR23_Exsum_fin_DP.pdf) Legitimate pharmaceutical dispensing of opiate-based analgesics, such as codeine for pain management, is excluded unless evidence indicates diversion, misuse, or dependence, aligning with UNODC's focus on problematic patterns contributing to public health burdens like overdose and addiction.[](https://www.unodc.org/res/WDR-2023/WDR23_Exsum_fin_DP.pdf) This exclusion prevents inflation of figures from routine medical practices, which vary widely by healthcare access and do not reflect the illicit markets central to global opiate prevalence assessments.[](https://www.unodc.org/documents/data-and-analysis/WDR_2024/WDR24_Key_findings_and_conclusions.pdf)\n\nThe post-2010 surge in synthetic opioid availability, driven by pharmaceutical production and illicit analogs like fentanyl, prompted a terminological pivot in some international reporting toward \"opioids\" for aggregated analysis of receptor-agonist substances.[](https://www.unodc.org/documents/scientific/Global_SMART_21_web_new.pdf) Nonetheless, UNODC data retain the opiates-opioids distinction, with opiates (predominantly heroin) accounting for 31.5 million users out of 60 million in non-medical opioid use globally in 2021, representing roughly 52% of the opioid burden.[](https://www.aidsdatahub.org/resource/unodc-world-drug-report-2023) This delineation underscores opiates' outsized role in regions reliant on opium cultivation, despite synthetics' rising dominance in overdose fatalities elsewhere.[](https://www.unodc.org/unodc/data-and-analysis/world-drug-report-2023.html)\n\n### Prevalence Indicators and Age Groups\n\nThe primary indicator for measuring opiate prevalence across countries is past-year prevalence, defined as the percentage of the population aged 15-64 who report having used opiates at least once in the preceding 12 months.[](https://dataunodc.un.org/sites/dataunodc.un.org/files/metadata_drug_use_and_treatment.pdf) This metric, standardized by the United Nations Office on Drugs and Crime (UNODC) since the early 2000s, enables consistent international comparisons by focusing on self-reported use from population-based surveys rather than indirect proxies like treatment admissions or seizures.[](https://www.unodc.org/res/WDR-2023/WDR23_Exsum_fin_DP.pdf)\n\nPrevalence estimates distinguish between lifetime use (ever having used opiates), past-year use (recent exposure), and past-month use (indicating more frequent or current patterns), with past-year serving as the benchmark for capturing both occasional and regular users while minimizing recall bias inherent in lifetime reports.[](https://www.unodc.org/res/wdr2022/MS/WDR22_Booklet_2.pdf) UNODC prioritizes verifiable data from general population surveys, household-based where possible, over clinical or overdose statistics, as the latter reflect severe outcomes rather than overall incidence and are prone to undercounting non-fatal use.[](https://www.unodc.org/res/WDR-2023/WDR23_Exsum_fin_DP.pdf)\n\nTo derive absolute numbers of users, prevalence rates are multiplied by the size of the target population (aged 15-64), yielding global estimates such as approximately 31.5 million opiate users in 2021, distinct from broader opioid figures that include synthetics like fentanyl.[](https://www.aidsdatahub.org/resource/unodc-world-drug-report-2023) This adjustment accounts for demographic variations but requires imputation for countries lacking direct surveys, using multipliers from neighboring regions or historical trends.[](https://www.unodc.org/documents/data-and-analysis/WDR_2025/Annex/WDR2025_Methodological_Annex.pdf)\n\n## Data Sources and Methodology\n\n### Primary International Sources\n\nThe United Nations Office on Drugs and Crime (UNODC) produces the World Drug Report annually since 2000, establishing it as the benchmark international compilation for opiate prevalence estimates derived from aggregated national-level data, including household surveys and indirect indicators like treatment admissions. These reports estimate past-year opiate use (primarily heroin and opium) among individuals aged 15-64, reporting a global prevalence of approximately 0.6% in recent assessments, equivalent to around 31 million users in 2021.[](https://www.unodc.org/unodc/data-and-analysis/world-drug-report-2025.html)[](https://www.euda.europa.eu/publications/eu-drug-markets/heroin-and-other-opioids/global-context_en) The 2025 edition, released on June 26, 2025, integrates data through 2023, noting persistent opiate use patterns amid increasing adulteration with synthetic opioids like fentanyl, which complicates purity measurement but does not alter core prevalence aggregation methods.[](https://www.unodc.org/documents/data-and-analysis/WDR_2025/WDR25_B1_Key_findings.pdf)[](https://unis.unvienna.org/unis/en/pressrels/2025/unisnar1499.html)\n\nThe World Health Organization (WHO) supports UNODC through aligned global estimates on drug use disorders, contributing data on opioid dependence that informs opiate-specific subsets, with 2021 figures indicating about 60 million non-medical opioid users worldwide, half of whom used opiates.[](https://www.who.int/news-room/fact-sheets/detail/opioid-overdose) WHO's methodologies emphasize epidemiological modeling for regions with sparse surveys, providing validation for UNODC's regional breakdowns.[](https://www.who.int/news-room/fact-sheets/detail/opioid-overdose)\n\nThe European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) offers supplementary regional data for Europe, harmonizing national reports to estimate opiate prevalence at around 0.4% for high-risk use among adults aged 15-64, often cross-referencing UNODC for global benchmarking.[](https://www.euda.europa.eu/publications/european-drug-report/2024_en)[](https://www.euda.europa.eu/publications/eu-drug-markets/heroin-and-other-opioids/global-context_en) EMCDDA's 2024 European Drug Report details opiate indicators like wastewater analysis and overdose statistics to refine estimates.[](https://www.euda.europa.eu/publications/european-drug-report/2024_en)\n\nOur World in Data aggregates UNODC prevalence figures into interactive visualizations, tracking opiate use trends from the early 2020s, such as stable global rates despite regional variations in Asia and Europe.\n\n### National Surveys and Estimation Techniques\n\nNational drug use prevalence is primarily assessed through nationally representative household surveys, which use probabilistic sampling to self-report lifetime, past-year, or past-month opiate consumption among the general population, typically those aged 15-64. These surveys form the core of data submitted by member states via the United Nations Office on Drugs and Crime's (UNODC) Annual Report Questionnaire (ARQ), a standardized aggregate reporting mechanism mandated under international drug control conventions and refined since the 2010s to improve consistency and coverage. However, household surveys often undercount opiate users due to the drug's association with stigmatized, hidden high-risk populations, prompting reliance on supplementary indicators like school-based surveys for youth or specialized key informant interviews.[](https://www.unodc.org/arq/)[](https://www.unodc.org/documents/ARQ/ARQ_Guidelines.pdf)[](https://wdr.unodc.org/wdr2019/prelaunch/WDR-2019-Methodology-FINAL.pdf)\n\nEstimation techniques emphasize triangulation of disparate sources to model total prevalence, combining household data with treatment admission records, law enforcement seizures, and indirect proxies for undetected use. For opiates, where direct surveys falter, multiplier methods derive total users from treatment seekers by applying context-specific ratios—such as benchmarks estimating untreated users based on administrative data like opioid agonist maintenance therapy enrollments—often indicating that only a minority of dependent individuals access formal care. Seizure data contributes indirectly by informing supply-side inferences, while capture-recapture and network scale-up approaches adjust for overlap and underreporting in hidden networks; data gaps in low-reporting countries are bridged via subregional imputation using weighted percentiles or regression extrapolations to facilitate cross-national comparability.[](https://www.unodc.org/documents/ARQ/ARQ_Guidelines.pdf)[](https://wdr.unodc.org/wdr2019/prelaunch/WDR-2019-Methodology-FINAL.pdf)[](https://www.unodc.org/pdf/gap_toolkit_module2.pdf)\n\nMethodological evolution has shifted from coarse 1990s extrapolations reliant on limited indicators to 2020s frameworks incorporating refined uncertainty ranges and underreporting corrections for factors like stigma, as detailed in UNODC's iterative World Drug Reports since 1997. ARQ revisions post-2010 enhanced indirect estimation protocols, prioritizing problem drug use metrics over general population snapshots for opiates, thereby yielding more robust global aggregates through expert-validated adjustments rather than unadjusted survey raw data.[](https://wdr.unodc.org/wdr2019/prelaunch/WDR-2019-Methodology-FINAL.pdf)[](https://www.unodc.org/res/wdr2022/MS/Statistical%2520Annex/WDR-2022-Methodology_final.docx)\n\n## Limitations of Available Data\n\n### Underreporting and Detection Biases\n\nSelf-reported surveys, which form the backbone of many prevalence estimates for opiate use, are susceptible to underreporting due to social desirability bias and reluctance to disclose illicit behaviors. Validation studies comparing self-reports to biological markers like urine or hair tests have consistently shown that respondents underreport illicit drug use, including opiates, with discrepancies most pronounced for recent or ongoing consumption.[](https://www.sciencedirect.com/science/article/abs/pii/S1047279721003549) [](https://substanceabusepolicy.biomedcentral.com/articles/10.1186/s13011-021-00398-3) This underreporting is amplified in jurisdictions with stringent enforcement regimes, where fear of prosecution or social stigma incentivizes concealment, as evidenced by higher discordance rates in criminal justice-involved samples.[](https://www.aic.gov.au/publications/tandi/tandi260) [](https://pmc.ncbi.nlm.nih.gov/articles/PMC4713294/)\n\nThe inherently clandestine nature of illicit opiate markets further obscures detection, as users often employ evasion tactics to avoid scrutiny, leading to incomplete capture in household or population-based surveys. Indirect indicators, such as overdose mortality statistics, primarily reflect acute endpoints rather than overall prevalence, systematically missing non-fatal or controlled use patterns that constitute the majority of consumption.[](https://journals.sagepub.com/doi/10.1177/002204269502500107) [](https://academic.oup.com/aje/article-pdf/149/10/955/413434/149-10-955.pdf)\n\nIn the 2020s, the proliferation of synthetic opioids, including fentanyl analogs mixed into heroin supplies, has introduced additional detection hurdles, as these potent substances can occur in microgram quantities that evade standard toxicological screening protocols. This shift contributes to underestimation of prevalence, particularly in regions where adulteration is rampant but routine testing lacks sensitivity for novel variants.[](https://www.consilium.europa.eu/en/policies/opioids-drugs-heroin/) [](https://www.sciencedirect.com/science/article/pii/S0034837625001408)\n\n### Temporal and Definitional Inconsistencies\n\nComparisons of opiate prevalence across countries are complicated by temporal lags in data collection and reporting, where estimates in recent global assessments often rely on surveys conducted several years earlier. For instance, the United Nations Office on Drugs and Crime's (UNODC) World Drug Report 2025 incorporates prevalence figures primarily from 2021 or earlier for many nations, potentially undercapturing rapid shifts such as post-COVID-19 surges in opioid-related disorders reported in regions like North America and Europe, where isolation and economic disruptions exacerbated use patterns.[](https://www.unodc.org/documents/data-and-analysis/WDR_2025/WDR25_B1_Key_findings.pdf) In some low-resource countries, the most recent available data dates to the early 2000s or 2010s, reflecting infrequent national household surveys and leading to outdated snapshots that fail to account for evolving trafficking routes or policy interventions.[](https://www.unodc.org/documents/data-and-analysis/WDR_2025/Annex/WDR2025_Methodological_Annex.pdf)\n\nDefinitional variations further hinder comparability, particularly the distinction between opiates and broader opioids. UNODC prevalence metrics focus predominantly on opiates—defined as natural and semi-synthetic substances like heroin, opium, and morphine—excluding synthetic opioids such as fentanyl and tramadol, which numbered approximately 28.5 million non-medical users globally in 2021 compared to 31.5 million opiate users.[](https://www.aidsdatahub.org/resource/unodc-world-drug-report-2023) This narrow scope inflates relative opiate prevalence estimates in Asia and the Near East, where traditional opiates dominate, while understating overall opioid burdens in the Americas, where synthetics drive over 75% of overdose deaths; such mismatches arise because national surveys and UNODC harmonization prioritize opiate-specific indicators for consistency with treaty obligations, yet overlook the ~30 million synthetic users in cross-regional rankings.[](https://www.unodc.org/res/WDR-2023/WDR23_Exsum_fin_DP.pdf)[](https://www.who.int/news-room/fact-sheets/detail/opioid-overdose)\n\nEfforts to mitigate these issues include UNODC's standardized estimation protocols, refined since the early 2010s through indirect methods like multiplier techniques and capture-recapture models when direct surveys are absent, but persistent gaps remain in data-sparse regions. Africa and Latin America, for example, suffer from survey intervals exceeding five years in many countries, compounded by underreporting in household polls that exclude high-risk populations like the homeless or incarcerated, thus perpetuating non-comparable aggregates despite global harmonization initiatives.[](https://www.unodc.org/pdf/gap_toolkit_module2.pdf)[](https://www.unodc.org/documents/data-and-analysis/WDR_2025/Annex/WDR2025_Methodological_Annex.pdf)\n\n## Global and Regional Patterns\n\n### Worldwide Prevalence Estimates\n\nThe global prevalence of past-year opiate use among individuals aged 15-64 years has remained stable at approximately 0.6% from 2010 to 2021, corresponding to an estimated 31.5 million users worldwide in 2021.[](https://www.aidsdatahub.org/resource/unodc-world-drug-report-2023) Opiates, encompassing opium, heroin, and morphine, represent the traditional subset of opioid substances, distinct from synthetic opioids such as fentanyl, which have driven broader opioid trends in certain regions. This stability reflects consistent production patterns, primarily from Afghanistan and Myanmar, balanced against varying demand and enforcement efforts, though underreporting in producer and transit countries likely understates true figures.\n\nIn the context of overall illicit drug use, opiates rank as the second most prevalent substance after cannabis, which affected 228 million past-year users in 2021.[](https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2024.html) Total past-year drug users reached 296 million that year, or about 5.8% of the global 15-64 population, with opiates comprising roughly 10% of this total.[](https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2024.html) Non-medical opioid use overall stood at 60 million, underscoring opiates' role amid rising synthetics, but opiate-specific estimates have not shown marked shifts pre-2022 due to methodological consistency in UNODC modeling, which integrates household surveys, treatment data, and seizure records.[](https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2024.html)\n\nPandemic-related disruptions from 2020 onward introduced slight upticks in drug use indicators, including potential opiate access challenges from border closures, though global opiate prevalence data lags beyond 2021. The UNODC's 2025 World Drug Report projects risks of elevated opiate use from instability in producer areas, notably following Afghanistan's 95% opiate market contraction post-2022 Taliban restrictions, which may spur demand-driven price surges or shifts to unregulated synthetics, complicating future estimates.[](https://www.issup.net/knowledge-share/resources/2024-08/2024-unodc-world-drug-report-highlights-brief-reflections-0) These trends highlight the need for enhanced monitoring, as supply shocks could reverse prior stability without adaptive interventions.\n\n### High-Prevalence Regions and Explanations\n\nThe regions exhibiting the highest prevalence of opiate use—primarily opium, heroin, and morphine—are concentrated in South-West Asia, the Near and Middle East, and South Asia, where annual prevalence rates among adults aged 15-64 average around 1.8% in the former areas, with specific locales surpassing 2%. This pattern aligns closely with the geography of the Golden Crescent, encompassing major poppy-producing territories in Afghanistan, Pakistan, and Iran, where cultivation volumes historically supplied over 80% of global illicit opium until a sharp 95% production decline in 2023 following enforcement measures. Proximity to these supply hubs fosters high availability, low prices, and cultural familiarity with opium consumption, driving empirical correlations between production intensity and use rates as documented in supply-demand modeling.[](https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2024.html)[](https://www.euda.europa.eu/publications/eu-drug-markets/heroin-and-other-opioids/global-context_en)\n\n![Flag of Iran](./_assets_/Flag_of_Iran.svg.png)\n\nSouth Asia sustains the world's largest opiate consumer base, with a regional prevalence of 1.1%, attributable to trafficking spillovers from the Golden Crescent and domestic factors like porous borders and historical trade routes. In contrast, South-East Asia near the Golden Triangle—Myanmar, Laos, and Thailand—shows elevated but variable rates tied to localized opium farming for ethnic minority subsistence and heroin processing, though synthetic shifts have moderated traditional opiate dominance. These areas demonstrate causal supply-side dynamics, where cultivation proximity reduces barriers to entry and sustains habitual use patterns unobserved in distal regions.[](https://www.euda.europa.eu/publications/eu-drug-markets/heroin-and-other-opioids/global-context_en)[](https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2024.html)\n\nPrevalence remains markedly lower in the Americas and Europe, at approximately 0.3-0.5%, reflecting greater distances from natural opiate production and a pivot toward synthetic opioids like fentanyl, which inflate absolute user counts without elevating traditional opiate shares. African data is sparse due to surveillance gaps, yet East African ports along southwest Asian heroin conduits report emerging hotspots, suggesting trafficking pathways as a vector for rising use amid weak interdiction. UNODC analyses confirm that deviations from global averages of 0.6% for opiates stem predominantly from geographic adjacency to the Golden Crescent and Triangle, emphasizing production-access linkages over isolated demand factors in explaining regional disparities.[](https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2024.html)[](https://www.euda.europa.eu/publications/eu-drug-markets/heroin-and-other-opioids/global-context_en)\n\n## Country-Specific Prevalence Data\n\n### Highest Prevalence Countries\n\nIran exhibits one of the highest rates of opiate use prevalence worldwide, with estimates ranging from 2.3% to 3.3% of the population aged 15-64 reporting past-year use in data spanning 2015-2021.[](https://www.unodc.org/islamicrepublicofiran/en/unodc-iran-supports-improving-health-conditions-of-inmates.html) This elevated level stems partly from its position as a primary transit corridor for opiates originating from neighboring Afghanistan, facilitating domestic availability and consumption, including traditional opium use.[](https://www.unodc.org/documents/wdr/WDR_2010/1.2_The_global_heroin_market.pdf)\n\nAfghanistan follows closely, with a reported opiate use prevalence of 2.65% among the 15-64 age group, based on UNODC assessments incorporating national surveys.[](https://www.apu.ac.jp/rcaps/uploads/fckeditor/publications/journal/RJAPS34_9_Haidary.pdf) Historical practices such as opium chewing, combined with the country's dominant role in global illicit opium production—accounting for over 80% in recent years—contribute to sustained high domestic consumption despite enforcement efforts.[](https://www.unodc.org/documents/crop-monitoring/Afghanistan/Afghanistan_opium_survey_2023.pdf)\n\nSeychelles and Egypt represent additional empirical outliers, with opiate prevalence estimates around 1.7% to 2.3% in comparable periods, exceeding the global average of approximately 0.6%. In Seychelles, heroin dependence affects roughly 10% of the adult population, indicative of broader opiate involvement amplified by limited resources and trafficking routes through Indian Ocean ports.[](https://www.bbc.com/news/world-africa-64785171) Egypt's figures reflect regional patterns in North Africa, influenced by proximity to production and underreporting in surveys. While percentage-based prevalence highlights these nations, absolute numbers of users are notably larger in populous countries like Pakistan and India due to scale, despite their moderate per-capita rates.\n\n### Lowest Prevalence Countries\n\nCountries in East Asia, including Japan and the Republic of Korea, report annual opiate use prevalence rates below 0.1% among the population aged 15-64, reflecting rigorous drug control measures and limited domestic production or trafficking routes for opiates.[](https://www.unodc.org/roseap/uploads/documents/Publications/2024/Synthetic_Drugs_in_East_and_Southeast_Asia_2024.pdf) National surveys in Japan from 2023 indicate negligible opiate involvement in overall drug use patterns, with methamphetamine and cannabis dominating reported cases instead.[](https://www.unodc.org/roseap/uploads/documents/Publications/2025/Synthetic_Drugs_in_East_and_Southeast_Asia_2025.pdf) Similarly, South Korea's enforcement-focused policies, including mandatory treatment and severe penalties, contribute to sustained low opiate indicators, with past-year use estimates remaining under detectable thresholds in household surveys up to 2022.\n\nMany African nations exhibit minimal reported opiate prevalence, often below 0.2%, as evidenced by limited national surveys and UNODC estimates for sub-Saharan regions where cannabis and other substances predominate over opiates.[](https://www.unodc.org/res/WDR-2023/WDR23_Exsum_fin_DP.pdf) For instance, countries like Nigeria show low opiate-specific use rates amid broader drug patterns, corroborated by low treatment demand data from 2021 surveys.[](https://www.eeas.europa.eu/node/57381_fr) These figures align with sparse seizure reports and hospital admissions for opiate-related issues, indicating genuine low exposure rather than solely data gaps.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC7269163/)\n\nIn Western and Central Europe, excluding outliers like the United Kingdom and Ireland, opiate prevalence typically falls below 0.2% based on 2020-2023 data from multiple OECD nations, with countries such as Germany, France, and Italy reporting rates under 0.5% for past-year opioid use.[](https://www.oecd.org/en/publications/2023/11/health-at-a-glance-2023_e04f8239/full-report/illicit-drug-use_ac094ca7.html)[](https://www.euda.europa.eu/publications/european-drug-report/2024_en) This pattern holds across harmonized European Monitoring Centre for Drugs and Drug Addiction indicators, where opiate use remains stable at low levels outside high-problematic-use pockets.[](https://www.euda.europa.eu/publications/eu-drug-markets/heroin-and-other-opioids/global-context_en) Low prevalence correlates with effective border controls and reduced heroin purity in these areas since the mid-2010s.[](https://www.unodc.org/documents/data-and-analysis/WDR_2024/WDR24_Key_findings_and_conclusions.pdf)\n\nVerification through indirect metrics, such as treatment entries and drug-induced mortality under 1 per 100,000 in these low-prevalence countries, supports the estimates despite potential underreporting in strict enforcement contexts.[](https://www.who.int/news-room/fact-sheets/detail/opioid-overdose) UNODC data from 2022-2024 consistently highlight these nations as exemplars of variability, where policy stringency appears linked to suppressed use rates.[](https://www.unodc.org/unodc/data-and-analysis/world-drug-report-2024.html)\n\n### Full Ranked List\n\nThe availability of comparable, recent data on opiate use prevalence remains limited, with UNODC relying on a combination of national household surveys, treatment data multipliers, and expert estimates for many countries; direct surveys are rare outside high-prevalence regions near opium production areas. The table below ranks countries with verifiable estimates from the past decade (post-2015), primarily drawn from UNODC datasets, sorted by descending annual prevalence rate among the population aged 15-64. Estimates denote past-year use of opiates (primarily heroin and opium, excluding synthetic opioids unless specified). Over 100 countries lack such recent figures, often due to underreporting in low-detection environments or absence of standardized surveys.[](https://www.unodc.org/unodc/data-and-analysis/world-drug-report-2024.html)\n\n| Country   | Prevalence (%) | Year | Notes/Source                  |\n|-----------|----------------|------|-------------------------------|\n| Iran     | 2.8           | 2021 | National estimate; high due to proximity to Afghanistan. UNODC World Drug Report 2023.[](https://www.unodc.org/unodc/frontpage/2022/August/baking_-a-possible-pathway-out-of-drug-use-for-women-in-kerman--iran.html) |\n| Afghanistan | 2.4       | 2015 | Survey-based; includes opium and heroin. UNODC estimates.70299-2/fulltext) |\n| Pakistan | 1.0           | 2017 | Regional multiplier model. UNODC data portal.[](https://dataunodc.un.org/content/country-profile) |\n| Uzbekistan| 0.93          | 2015 | National survey. UNODC.[](https://dataunodc.un.org/) |\n| Malaysia | 0.94          | 2017 | Treatment and seizure-adjusted estimate. UNODC.[](https://dataunodc.un.org/) |\n| Mauritius| 0.91          | 2017 | Household survey. UNODC regional data.[](https://dataunodc.un.org/content/country-list) |\n\nData gaps persist for most nations, with global opiate prevalence averaging 0.6% in 2021 per UNODC, but country-level figures often extrapolated rather than surveyed.[](https://www.euda.europa.eu/publications/eu-drug-markets/heroin-and-other-opioids/global-context_en) For restrictive regimes or low-use areas, estimates may understate true rates due to stigma and weak reporting systems.[](https://www.unodc.org/unodc/data-and-analysis/world-drug-report-2023.html)\n\n## Correlates and Causal Factors\n\n### Socioeconomic and Geographic Influences\n\n![Opium production hub](./_assets_/Flag_of_the_Taliban.svg.png)\nOpiate use prevalence exhibits a strong geographic pattern tied to proximity to primary production centers, particularly in South-West Asia where Afghanistan dominates global illicit opium output. In 2022, Afghanistan accounted for 80% of worldwide illicit opium production, estimated at 6,200 tonnes out of 7,800 tonnes total, facilitating spillover into adjacent transit and consumption markets.[](https://www.euda.europa.eu/publications/eu-drug-markets/heroin-and-other-opioids/production_en) This adjacency correlates with elevated regional prevalence rates, such as in the Near and Middle East/South-West Asia subregion, where opiate use remains among the highest globally due to easier access via smuggling routes.\n\nSocioeconomic factors show an inverse association with opiate use, with higher prevalence observed in low-income countries serving as transit hubs. Analysis across Asian nations indicates a negative correlation between opiate abuse rates and GDP per capita (r = -0.31, p = 0.055), suggesting that economic disadvantage in production-adjacent states amplifies vulnerability through limited resources for prevention and treatment.[](https://www.sop.org.tw/sop_journal/pastIssues/info_PdfFiles.asp?/1475.html) However, while datasets consistently reveal this pattern in low-GDP transit economies like those in Central Asia and the Middle East, direct causation from poverty alone lacks empirical proof, as confounding geographic and supply factors dominate observed trends.\n\nUrbanization and population displacement further exacerbate prevalence as amplifiers of exposure. UNODC data highlights how rapid urban growth and migration flows increase drug availability in densely populated areas, with irregular migrants showing drug use rates up to 61.3%, often involving opiates amid transit stresses.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC8352205/) In conflict-affected zones, empirical evidence points to 2-3 times higher opiate use rates compared to stable regions, driven by trauma, disrupted social structures, and opportunistic trafficking, though these patterns hold across multiple datasets without isolating socioeconomic drivers from violence itself.[](https://conflictandhealth.biomedcentral.com/articles/10.1186/s13031-021-00407-z)[](https://www.unodc.org/documents/data-and-analysis/WDR_2025/WDR25_Special_points_of_interest.pdf)\n\n### Drug Policy Enforcement Effects\n\nCountries implementing rigorous drug enforcement, particularly supply-side interdiction and severe penalties for possession and trafficking, demonstrate correlations with markedly lower opiate prevalence rates. In Singapore, where possession of small amounts can result in mandatory rehabilitation or imprisonment and trafficking carries the death penalty, annual opiate use prevalence remains below 0.1%, with urine testing and strict border controls contributing to sustained low levels reported in national surveys.[](https://www.cnb.gov.sg/docs/default-source/drug-situation-report-documents/cnb-annual-statistics-2023.pdf) Similarly, Japan's comprehensive narcotics laws, emphasizing zero tolerance and high conviction rates, align with opiate use rates under 0.1% in the general population, as evidenced by nationwide surveys showing minimal illicit opioid involvement compared to other substances.[](https://www.ncnp.go.jp/nimh/yakubutsu/report/pdf/2017_0522_2015EN_shimane2_k.pdf) These Asian examples contrast with higher prevalence in contexts of lax enforcement or state fragility, such as Afghanistan, where opiate use exceeds 2.5% amid limited central control over production and trafficking routes.[](https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2024.html)\n\nUnited Nations Office on Drugs and Crime (UNODC) analyses indicate that effective enforcement disrupts supply chains, reducing availability and thereby curbing use, particularly for supply-driven opiates like heroin. Global seizure data from UNODC reports show inverse patterns: regions with intensified interdiction, such as parts of East Asia, experience depressed prevalence following spikes in opium and heroin seizures, suggesting causal links through diminished street-level access rather than demand-side factors alone.[](https://www.unodc.org/documents/data-and-analysis/WDR_2025/WDR25_B1_Key_findings.pdf) In Iran, border fortifications and aggressive anti-trafficking operations post-2000, including mass executions for major traffickers, coincided with temporary dips in domestic prevalence from peaks above 3% in the 1990s to around 2.1% by the 2010s, though proximity to Afghan supply limits full eradication.[](https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-022-00719-0)\n\nConversely, the United States illustrates how permissive legal supply channels can elevate prevalence despite parallel illicit enforcement efforts. The opioid crisis escalated in the 2010s with prescription rates surging to over 250 million annually by 2012, driving non-medical use prevalence to 1.5% for opioids excluding heroin, as lax regulatory oversight on pharmaceutical distribution outpaced interdiction impacts.[](https://www.cdc.gov/overdose-prevention/about/understanding-the-opioid-overdose-epidemic.html) Subsequent prescription curbs post-2016 correlated with declines in prescription-related overdoses by 33%, underscoring enforcement's role in constraining supply vectors, though synthetic shifts like fentanyl sustained high overall use.[](https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2024.html) These patterns affirm that prevalence more closely tracks interdiction efficacy and supply controls than isolated education or treatment initiatives.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3787412/)\n\n## Debates on Data Interpretation\n\n### Reliability of Estimates in Restrictive Regimes\n\nIn countries characterized by stringent drug prohibition and limited civil liberties, such as China and Saudi Arabia, official estimates of opiate prevalence often register at or near zero, with China's registered drug users numbering approximately 2.4 million in 2021 (predominantly methamphetamine rather than opiates) out of a population exceeding 1.4 billion, implying an opiate-specific rate below 0.1%.[](http://losangeles.china-consulate.gov.cn/eng/topnews/202306/t20230628_11104750.htm) These figures derive from government-monitored registration systems enforced under severe penalties, including execution for trafficking, which incentivize non-disclosure and raise questions of systematic undercounting.[](https://pubmed.ncbi.nlm.nih.gov/16669899/) Triangulation with indirect indicators, such as border seizures and treatment admissions, reveals potential gaps; for instance, early 2000s analyses estimated China's actual opiate addict population at several times the registered 1.14 million, though recent data show stabilization at low levels.[](https://pubmed.ncbi.nlm.nih.gov/16669899/)\n\nIndependent verification methods, including wastewater-based epidemiology, offer a counterpoint to self-reported or registered data, detecting biomarkers of opiate metabolites in sewage to estimate community consumption objectively. In China, nationwide expansion of such monitoring since 2018 has documented significant declines in heroin and other opiate residues, aligning with official reports of reduced use amid aggressive interdiction campaigns, rather than indicating concealed epidemics.[](https://www.nature.com/articles/d41586-018-05728-3)[](http://losangeles.china-consulate.gov.cn/eng/topnews/202306/t20230628_11104750.htm) Similarly, in Saudi Arabia, where opiate prevalence is reported at under 0.1% through national surveys under Sharia-influenced prohibitions, limited wastewater and forensic studies corroborate low population-level exposure, though subgroup analyses (e.g., among youth) detect sporadic misuse not captured in aggregates.[](https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-024-21190-5)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC10491761/)\n\nComparisons with liberal democracies highlight discrepancies: the United States, with self-reported opiate use disorder rates around 1-2% via anonymous surveys, contrasts sharply with restrictive regimes' figures, but this gap persists even after adjusting for methodological differences, as evidenced by cross-national validations showing enforcement correlates with lower biomarker-detected consumption. Claims of pervasive underreporting in authoritarian contexts—often advanced in academic critiques assuming equivalence to open-society stigma—overstate distortions, as empirical proxies like wastewater yield consistent low signals where penalties deter supply and demand effectively, prioritizing causal enforcement impacts over unsubstantiated concealment narratives.[](https://www.sciencedirect.com/science/article/pii/S0043135421009830)[](https://www.nature.com/articles/d41586-018-05728-3)\n\n### Policy Efficacy Versus Reported Prevalence\n\nProponents of stringent drug enforcement policies cite empirical correlations between harsh penalties and reduced opiate use prevalence, as observed in jurisdictions like Singapore, where lifetime illicit drug consumption rates remain among the lowest globally at approximately 3-5% of the adult population, with opiate-specific abuse estimated at 30 per 100,000 people compared to 600 in the United States.[](https://annals.edu.sg/prevalence-of-consumption-of-illicit-drugs-and-associated-factors-from-a-nationwide-epidemiological-survey-the-singapore-health-and-lifestyle-survey/)[](https://www.washingtonpost.com/opinions/singapore-is-winning-the-war-on-drugs-heres-how/2018/03/11/b8c25278-22e9-11e8-946c-9420060cb7bd_story.html) Singapore's framework, including mandatory rehabilitation and capital punishment for trafficking, has sustained these low figures since the 1970s, contrasting with higher-use environments and supporting causal claims that deterrence curbs initiation and sustained use.[](https://www.unodc.org/documents/data-and-analysis/Studies/100_Years_of_Drug_Control.pdf)\n\nIn contrast, Portugal's 2001 decriminalization, often lauded by harm reduction advocates for slashing HIV infections and overdose deaths by over 80% in the ensuing decade, coincided with stable or modestly declining lifetime opiate prevalence rates across age groups, yet high-risk opioid users per capita exceeded the European average as of 2015, with estimates around 33,000 individuals.[](https://ftp.iza.org/dp10895.pdf)[](https://transformdrugs.org/blog/drug-decriminalisation-in-portugal-setting-the-record-straight) Critics of punitive approaches, drawing from academic and NGO sources, contend that low reported prevalence in enforcement-heavy systems masks underground use and unaddressed harms, potentially inflating black-market risks; however, opiate-specific metrics, including treatment uptake and overdose incidence, do not consistently validate this for strict regimes, where both prevalence and fatalities remain subdued absent widespread harm reduction infrastructure.[](https://obamawhitehouse.archives.gov/sites/default/files/ondcp/Fact_Sheets/portugal_fact_sheet_8-25-10.pdf)\n\nThe United Nations Office on Drugs and Crime's 2025 World Drug Report underscores that global instability—encompassing conflicts, economic disruptions, and trafficking adaptations—elevates opiate consumption irrespective of policy stringency, with record-high use affecting 6% of the global population amid synthetic opioid surges.[](https://www.unodc.org/unodc/data-and-analysis/world-drug-report-2025.html)[](https://unis.unvienna.org/unis/en/pressrels/2025/unisnar1499.html) This highlights the limits of attributing prevalence solely to enforcement efficacy, as supply proximity and socioeconomic pressures exert stronger causal influences; nonetheless, cross-national data prioritize verifiable prevalence reductions in high-enforcement contexts over interpretive claims from ideologically aligned sources, which often underemphasize deterrence's role in empirical outcomes.[](https://www.unodc.org/documents/data-and-analysis/WDR_2025/WDR25_B1_Key_findings.pdf) Such analyses reveal punitive policies' comparative success in constraining use where implementable, though not as panacea against exogenous drivers."])</script><script nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx">self.__next_f.push([1,"8:[\"$\",\"$L1e\",null,{\"state\":{\"mutations\":[],\"queries\":[{\"dehydratedAt\":1761885275655,\"state\":{\"data\":{\"page\":{\"citations\":[{\"id\":\"1\",\"title\":\"\",\"description\":\"\",\"url\":\"https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2024.html\",\"favicon\":\"\"},{\"id\":\"2\",\"title\":\"dp-drug-use-prevalence - dataUNODC |\",\"description\":\"Prevalence of Drug Use in the General Population (excluding NPS). Annual Prevalence of Use as a percentage of the population aged 15-64 (unless otherwise ...\",\"url\":\"https://dataunodc.un.org/dp-drug-use-prevalence\",\"favicon\":\"\"},{\"id\":\"3\",\"title\":\"EU Drug Market: Heroin and other opioids — Global context\",\"description\":\"South Asia is the largest consumer market for opiates worldwide, with 1.1 % prevalence of opiate use, almost twice the estimated global average (UNODC, 2023a).\u003c|separator|\u003e\",\"url\":\"https://www.euda.europa.eu/publications/eu-drug-markets/heroin-and-other-opioids/global-context_en\",\"favicon\":\"\"},{\"id\":\"4\",\"title\":\"[PDF] World Drug Report 2020 - unodc\",\"description\":\"The population of. South Asia accounts for approximately 20 per cent of the global population aged 15–64 and more than one third of the estimated number of ...\",\"url\":\"https://wdr.unodc.org/wdr2020/field/WDR20_Booklet_2.pdf\",\"favicon\":\"\"},{\"id\":\"5\",\"title\":\"Baking: a possible pathway out of drug use for women in Kerman, Iran\",\"description\":\"Aug 24, 2022 · ... drug use problem, Iran also has one of the world's highest prevalence of opiate use among its population. Women are among the affected – one ...\",\"url\":\"https://www.unodc.org/unodc/frontpage/2022/August/baking_-a-possible-pathway-out-of-drug-use-for-women-in-kerman--iran.html\",\"favicon\":\"\"},{\"id\":\"6\",\"title\":\"[PDF] Metadata Information Drug Use and Treatment - Data UNODC\",\"description\":\"Jun 26, 2025 · The tables on drug use and treatment include figures on prevalence of drug use at national, regional, and global levels, and figures on people ...\",\"url\":\"https://dataunodc.un.org/sites/dataunodc.un.org/files/metadata_drug_use_and_treatment.pdf\",\"favicon\":\"\"},{\"id\":\"7\",\"title\":\"[PDF] Terminology and Information on Drugs\",\"description\":\"The pharmacological effects of morphine, heroin and other opiates are mediated through their interaction with opioid receptors and inhibitory neurotransmitters.Missing:  shift | Show results with:shift\u003c|control11|\u003e\u003c|separator|\u003e\",\"url\":\"https://www.unodc.org/documents/scientific/Terminology_English.pdf\",\"favicon\":\"\"},{\"id\":\"8\",\"title\":\"World Drug Report 2023 - Unodc\",\"description\":\"... Drug Report 2023, focuses on the countries affected by drug trafficking and related crime issues, hosting the largest share of the Amazon Basin rainforest ...Executive Summary · Special Points of Interest · Statistical Annex\",\"url\":\"https://www.unodc.org/unodc/data-and-analysis/world-drug-report-2023.html\",\"favicon\":\"\"},{\"id\":\"9\",\"title\":\"[PDF] World Drug Report 2023 - UNODC\",\"description\":\"Eastern Europe (1.3 per cent of the adult population) and North America (1.0 per cent) remain the two subregions with the highest estimated prevalence of ...\",\"url\":\"https://www.unodc.org/res/WDR-2023/WDR23_Exsum_fin_DP.pdf\",\"favicon\":\"\"},{\"id\":\"10\",\"title\":\"[PDF] KEY FINDINGS AND CONCLUSIONS\",\"description\":\"I am proud to present the 2024 edition of UNODC's flag- ship World Drug Report, which delves into the major developments in the manufacture and trafficking ...\",\"url\":\"https://www.unodc.org/documents/data-and-analysis/WDR_2024/WDR24_Key_findings_and_conclusions.pdf\",\"favicon\":\"\"},{\"id\":\"11\",\"title\":\"[PDF] Understanding the global opioid crisis - Unodc\",\"description\":\"Mar 21, 2019 · heroin and morphine have contributed to opioid users shifting to cheaper and more easily available opioids. ... deaths involving heroin from 2010 ...\",\"url\":\"https://www.unodc.org/documents/scientific/Global_SMART_21_web_new.pdf\",\"favicon\":\"\"},{\"id\":\"12\",\"title\":\"UNODC, World Drug Report 2023 | HIV/AIDS Data Hub for the Asia ...\",\"description\":\"The estimated number of users grew from 240 million in 2011 to 296 million in 2021 (5.8 per cent of the global population aged 15–64). This is a 23 per cent ...\u003c|separator|\u003e\",\"url\":\"https://www.aidsdatahub.org/resource/unodc-world-drug-report-2023\",\"favicon\":\"\"},{\"id\":\"13\",\"title\":\"[PDF] World Drug Report 2022 - UNODC\",\"description\":\"the distinctions between “drug use”, “drug misuse” and. “drug abuse”, the ... (lifetime, past 12 months, past month) and by targeting similar age groups ...\",\"url\":\"https://www.unodc.org/res/wdr2022/MS/WDR22_Booklet_2.pdf\",\"favicon\":\"\"},{\"id\":\"14\",\"title\":\"[PDF] World Drug Report 2025 Methodological Annex\",\"description\":\"of cannabis in the age group 15-64, as well as global prevalence of past-year cannabis use among 15-64 year-olds and 15-16 year-olds, described above, was used.\",\"url\":\"https://www.unodc.org/documents/data-and-analysis/WDR_2025/Annex/WDR2025_Methodological_Annex.pdf\",\"favicon\":\"\"},{\"id\":\"15\",\"title\":\"World Drug Report 2025 - Unodc\",\"description\":\"World Drug Report 2025. PreviousNext. A global reference on drug markets, trends and policy developments, the World Drug Report offers a wealth of data and ...Drug market patterns and trends · Key findings · Special Points of Interest · Maps\",\"url\":\"https://www.unodc.org/unodc/data-and-analysis/world-drug-report-2025.html\",\"favicon\":\"\"},{\"id\":\"16\",\"title\":\"[PDF] World Drug Report 2025 - UNODC\",\"description\":\"Jun 13, 2025 · In terms of weight, synthetic opioids were the second most seized group of synthetic drugs worldwide in 2023, with fentanyl dominating in terms ...\",\"url\":\"https://www.unodc.org/documents/data-and-analysis/WDR_2025/WDR25_B1_Key_findings.pdf\",\"favicon\":\"\"},{\"id\":\"17\",\"title\":\"UNODC World Drug Report 2025: Global instability compounding ...\",\"description\":\"Jun 26, 2025 · This edition of the World Drug Report shows that organized drug trafficking groups continue to adapt, exploit global crises, and target vulnerable populations.Missing:  prevalence | Show results with:prevalence\",\"url\":\"https://unis.unvienna.org/unis/en/pressrels/2025/unisnar1499.html\",\"favicon\":\"\"},{\"id\":\"18\",\"title\":\"Opioid overdose - World Health Organization (WHO)\",\"description\":\"Aug 29, 2025 · Worldwide, about 296 million people (or 5.8% of the global population aged 15–64 years) used drugs at least once in 2021. Among them, about 60 ...\",\"url\":\"https://www.who.int/news-room/fact-sheets/detail/opioid-overdose\",\"favicon\":\"\"},{\"id\":\"19\",\"title\":\"European Drug Report 2024: Trends and Developments\",\"description\":\"Jun 14, 2024 · On this page, you can find the latest analysis of the drug situation for heroin and other opioids in Europe, including prevalence of use, ...Understanding Europe’s drug... · Drug-induced deaths · Cocaine · Cannabis\u003c|separator|\u003e\",\"url\":\"https://www.euda.europa.eu/publications/european-drug-report/2024_en\",\"favicon\":\"\"},{\"id\":\"20\",\"title\":\"Annual Report Questionnaire (ARQ) - unodc\",\"description\":\"The ARQ is a mandated data collection which gathers aggregate data and information on a wide range of subjects related to drugs.\",\"url\":\"https://www.unodc.org/arq/\",\"favicon\":\"\"},{\"id\":\"21\",\"title\":\"[PDF] Guidelines for the Annual Report Questionnaire\",\"description\":\"Indirect methods for the estimation of drug prevalence. Indirect methods for the estimation of prevalence of drug use are methods used to estimate the “hidden” ...\",\"url\":\"https://www.unodc.org/documents/ARQ/ARQ_Guidelines.pdf\",\"favicon\":\"\"},{\"id\":\"22\",\"title\":\"[PDF] World Drug Report 2019 Methodology Report\",\"description\":\"For example, it is generally accepted that nationally representative household surveys are reasonably good approaches to estimating cannabis, ATS or cocaine use ...\",\"url\":\"https://wdr.unodc.org/wdr2019/prelaunch/WDR-2019-Methodology-FINAL.pdf\",\"favicon\":\"\"},{\"id\":\"23\",\"title\":\"[PDF] Indirect Methods for Estimating the Size of the Drug Problem\",\"description\":\"Prevalence estimates arising from surveys of the general population—surveys that are usually based on sampling households and using self-reporting of drug- ...\",\"url\":\"https://www.unodc.org/pdf/gap_toolkit_module2.pdf\",\"favicon\":\"\"},{\"id\":\"24\",\"title\":\"[DOC] Methodology - United Nations Office on Drugs and Crime\",\"description\":\"UNODC does not publish estimates of the prevalence of drug use in countries with smaller populations (less than approximately 100,000 population aged 15-64) ...\",\"url\":\"https://www.unodc.org/res/wdr2022/MS/Statistical%2520Annex/WDR-2022-Methodology_final.docx\",\"favicon\":\"\"},{\"id\":\"25\",\"title\":\"What is the prevalence of drug use in the general population ...\",\"description\":\"Studies comparing self-report to test results from urine, saliva, and/or hair have uncovered extensive underreporting of drug use in both general and high-risk ...Missing:  opiate | Show results with:opiate\",\"url\":\"https://www.sciencedirect.com/science/article/abs/pii/S1047279721003549\",\"favicon\":\"\"},{\"id\":\"26\",\"title\":\"Validity of self-reported substance use: research setting versus ...\",\"description\":\"Sep 14, 2021 · In a study, Harrison found that underreporting had little or no effect on self-reported lifetime use, more on self-reported use past year, and ...\",\"url\":\"https://substanceabusepolicy.biomedcentral.com/articles/10.1186/s13011-021-00398-3\",\"favicon\":\"\"},{\"id\":\"27\",\"title\":\"Self-reported drug use: how prevalent is under-reporting?\",\"description\":\"Jun 1, 2003 · In the criminal justice environment the fear of punishment may be heightened if respondents perceive that supplying accurate information could ...\",\"url\":\"https://www.aic.gov.au/publications/tandi/tandi260\",\"favicon\":\"\"},{\"id\":\"28\",\"title\":\"VALIDITY OF SELF-REPORTED DRUG USE INFORMATION ... - NIH\",\"description\":\"This study assesses validity of self-report for the use of major classes of illicit drugs and opioid-maintenance therapy among pregnant women\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC4713294/\",\"favicon\":\"\"},{\"id\":\"29\",\"title\":\"The Validity of Self-Reported Data on Drug Use - Sage Journals\",\"description\":\"This paper reviews these studies and their implications for the validity of self-report in epidemiological drug surveys.\",\"url\":\"https://journals.sagepub.com/doi/10.1177/002204269502500107\",\"favicon\":\"\"},{\"id\":\"30\",\"title\":\"A Comparison of Cocaine and Heroin Survey Reports with Hair Test\",\"description\":\"The findings presented in this report suggest that survey reports of cocaine and heroin use do not pro- vide an accurate picture of the prevalence of drug use ...\u003c|separator|\u003e\",\"url\":\"https://academic.oup.com/aje/article-pdf/149/10/955/413434/149-10-955.pdf\",\"favicon\":\"\"},{\"id\":\"31\",\"title\":\"Opioids: a new drug threat for Europe - consilium.europa.eu\",\"description\":\"It is particularly challenging to detect synthetic opioids since they may be present in other drugs or substances in minuscule amounts, which may evade routine ...\",\"url\":\"https://www.consilium.europa.eu/en/policies/opioids-drugs-heroin/\",\"favicon\":\"\"},{\"id\":\"32\",\"title\":\"Fentanyl and other New Psychoactive Synthetic Opioids ...\",\"description\":\"Clinicians must consider that commonly available antidoping kits may not detect fentanyl analogs and other new synthetic opioids and stay alert to symptoms ...Missing:  factsheet | Show results with:factsheet\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S0034837625001408\",\"favicon\":\"\"},{\"id\":\"33\",\"title\":\"2024 UNODC World Drug Report Highlights, brief reflections - ISSUP\",\"description\":\"Aug 19, 2024 · Opioids were noted to remain a significant contributor to the global burden of disease, continuing to contribute remarkably to treatment demand ...\",\"url\":\"https://www.issup.net/knowledge-share/resources/2024-08/2024-unodc-world-drug-report-highlights-brief-reflections-0\",\"favicon\":\"\"},{\"id\":\"34\",\"title\":\"UNODC Iran Supports improving Health Conditions of Inmates\",\"description\":\"UNODC works towards advocating for harm reduction programs within the Iranian penitentiary system, specifically targeting individuals with drug dependencies.\",\"url\":\"https://www.unodc.org/islamicrepublicofiran/en/unodc-iran-supports-improving-health-conditions-of-inmates.html\",\"favicon\":\"\"},{\"id\":\"35\",\"title\":\"[PDF] 1.2 The global heroin market - Unodc\",\"description\":\"Only 35% of all countries and territories (76 out of 217) provided data on opiate prevalence rates in the 2008 ARQ; 141 (65%) did not provide data. Out of this ...\",\"url\":\"https://www.unodc.org/documents/wdr/WDR_2010/1.2_The_global_heroin_market.pdf\",\"favicon\":\"\"},{\"id\":\"36\",\"title\":\"[PDF] Socioeconomic factors associated with opioid drug use among the ...\",\"description\":\"Afghanistan, Iran, and the central Asian countries continue to be parts of the world with a higher incidence of opiate users than the global average. In the.\",\"url\":\"https://www.apu.ac.jp/rcaps/uploads/fckeditor/publications/journal/RJAPS34_9_Haidary.pdf\",\"favicon\":\"\"},{\"id\":\"37\",\"title\":\"[PDF] Afghanistan opium survey 2023 - UNODC\",\"description\":\"In terms of locations for opium seizure events suggestive of trafficking, Iran (Islamic Republic of) reports the greatest share, especially since mid-2021 when ...Missing:  prevalence | Show results with:prevalence\",\"url\":\"https://www.unodc.org/documents/crop-monitoring/Afghanistan/Afghanistan_opium_survey_2023.pdf\",\"favicon\":\"\"},{\"id\":\"38\",\"title\":\"Seychelles: The island paradise held prisoner by heroin - BBC\",\"description\":\"Mar 5, 2023 · It is estimated that around 10% of the Seychellois population is hooked on heroin. So much so that foreign workers are having to be brought in ...Missing:  prevalence | Show results with:prevalence\",\"url\":\"https://www.bbc.com/news/world-africa-64785171\",\"favicon\":\"\"},{\"id\":\"39\",\"title\":\"[PDF] Synthetic Drugs in East and Southeast Asia - Unodc\",\"description\":\"2023. Source: National Center of Neurology and Psychiatry (NCNP), “2023. Nationwide General Population Survey on Drug Use in Japan”, March. 2024 (available at ...\",\"url\":\"https://www.unodc.org/roseap/uploads/documents/Publications/2024/Synthetic_Drugs_in_East_and_Southeast_Asia_2024.pdf\",\"favicon\":\"\"},{\"id\":\"40\",\"title\":\"[PDF] Synthetic Drugs in East and Southeast Asia - unodc\",\"description\":\"May 10, 2025 · Drug demand indicators. Table 1. Trends in use of selected drugs in Japan, 2011-2023. Drug type. 2011. 2013. 2015. 2017. 2019. 2021. 2023.\",\"url\":\"https://www.unodc.org/roseap/uploads/documents/Publications/2025/Synthetic_Drugs_in_East_and_Southeast_Asia_2025.pdf\",\"favicon\":\"\"},{\"id\":\"41\",\"title\":\"Nigeria, EU and UNODC release first-ever National Drug Use Survey\",\"description\":\"The data suggests that the prevalence of past year drug use in Nigeria is more than twice the global average of 5.6 per cent. Based on data collected from ...\u003c|control11|\u003e\u003c|separator|\u003e\",\"url\":\"https://www.eeas.europa.eu/node/57381_fr\",\"favicon\":\"\"},{\"id\":\"42\",\"title\":\"The Opioid Epidemic in Africa And Its Impact - PMC - PubMed Central\",\"description\":\"Jun 3, 2020 · In contrast, opioids for clinical pain management in Africa remain among the least available globally. This region also has the highest HIV and ...Missing:  Japan Korea\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC7269163/\",\"favicon\":\"\"},{\"id\":\"43\",\"title\":\"Illicit drug use: Health at a Glance 2023 | OECD\",\"description\":\"On average across 22 OECD countries, an estimated 0.9% of people aged 15‑64 had used either prescription opioids or opiates in the last 12 months. Opioid use ...\",\"url\":\"https://www.oecd.org/en/publications/2023/11/health-at-a-glance-2023_e04f8239/full-report/illicit-drug-use_ac094ca7.html\",\"favicon\":\"\"},{\"id\":\"44\",\"title\":\"World Drug Report 2024 - Unodc\",\"description\":\"A global reference on drug markets, trends and policy developments, the World Drug Report offers a wealth of data and analysis and in 2024 comprises several ...Drug market patterns and trends · Key findings and conclusions · Statistical Annex\",\"url\":\"https://www.unodc.org/unodc/data-and-analysis/world-drug-report-2024.html\",\"favicon\":\"\"},{\"id\":\"45\",\"title\":\"Country Profile | dataUNODC - the United Nations\",\"description\":\"The chart shows a combination of annual prevalence of drug use (best estimate) and global estimate for each drug type.\",\"url\":\"https://dataunodc.un.org/content/country-profile\",\"favicon\":\"\"},{\"id\":\"46\",\"title\":\"dataUNODC |\",\"description\":\"Welcome to UNODC Data portal · Drug Use \u0026 Treatment · Drug Trafficking \u0026 Cultivation · Intentional Homicide · Violent \u0026 Sexual Crime · Corruption \u0026 Economic Crime.Drug Use \u0026 Treatment · Dp-drug-seizures · Dp-intentional-homicide-victims\",\"url\":\"https://dataunodc.un.org/\",\"favicon\":\"\"},{\"id\":\"47\",\"title\":\"Country list - dataUNODC |\",\"description\":\"Prevalence of Drug Use in the General Population (excluding NPS) - Population aged: 15- 64. Year: 2017. Press Enter to explore data.\",\"url\":\"https://dataunodc.un.org/content/country-list\",\"favicon\":\"\"},{\"id\":\"48\",\"title\":\"EU Drug Market: Heroin and other opioids — Production of opioids\",\"description\":\"The announcement of the ban has influenced the reported 248 % increase in the average national opium price in 2022 (to USD 219 per kilogram) (UNODC, 2022b).\",\"url\":\"https://www.euda.europa.eu/publications/eu-drug-markets/heroin-and-other-opioids/production_en\",\"favicon\":\"\"},{\"id\":\"49\",\"title\":\"[PDF] The Correlation of Drug Abuse and Gross Domestic Product in Asian ...\",\"description\":\"The number of abusing opiate was found to be negatively correlated with GDP but with significant trend. (r= -0.31, p = 0.055, n=39). Opiate abuse was found to ...\",\"url\":\"https://www.sop.org.tw/sop_journal/pastIssues/info_PdfFiles.asp?/1475.html\",\"favicon\":\"\"},{\"id\":\"50\",\"title\":\"The prevalence of drug use and illicit trafficking: A descriptive cross ...\",\"description\":\"Drug use prevalence in irregular migration among study participants is 61.3%. Alcohol and marijuana is mostly the drug use among irregular migrants.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC8352205/\",\"favicon\":\"\"},{\"id\":\"51\",\"title\":\"Priorities for addressing substance use disorder in humanitarian ...\",\"description\":\"Sep 23, 2021 · Populations affected by humanitarian emergencies may experience an elevated vulnerability to alcohol and other drug use disorders, hereafter ...\",\"url\":\"https://conflictandhealth.biomedcentral.com/articles/10.1186/s13031-021-00407-z\",\"favicon\":\"\"},{\"id\":\"52\",\"title\":\"[PDF] SPECIAL POINTS OF INTEREST - unodc\",\"description\":\"Impact of drug use is influenced by individual and contextual factors (modifiers). Conflict. Stigma and discrimination. Cultural factors. Availability of ...Missing:  urbanization | Show results with:urbanization\",\"url\":\"https://www.unodc.org/documents/data-and-analysis/WDR_2025/WDR25_Special_points_of_interest.pdf\",\"favicon\":\"\"},{\"id\":\"53\",\"title\":\"[PDF] CNB Annual Statistics 2023 - Central Narcotics Bureau\",\"description\":\"1,621 methamphetamine abusers (52%), 1,039 heroin abusers (33%), and 276 cannabis abusers (9%) were arrested in 2023. Refer to Chart 2.Missing:  opiate | Show results with:opiate\",\"url\":\"https://www.cnb.gov.sg/docs/default-source/drug-situation-report-documents/cnb-annual-statistics-2023.pdf\",\"favicon\":\"\"},{\"id\":\"54\",\"title\":\"[PDF] 2015 Nationwide General Population Survey on Drug Use in Japan\",\"description\":\"The proportion of respondents having knowledge of harmful effects of NPSs increased from. 61.5% (2013) to 85.8% (2015), with 56.9% of respondents having ...\",\"url\":\"https://www.ncnp.go.jp/nimh/yakubutsu/report/pdf/2017_0522_2015EN_shimane2_k.pdf\",\"favicon\":\"\"},{\"id\":\"55\",\"title\":\"Ups and downs of addiction harm reduction in Iran: key insights and ...\",\"description\":\"Jan 20, 2023 · This article addresses the impact of ideology, social conditions, and bureaucratic administration on the relationship between the health system and the police ...\",\"url\":\"https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-022-00719-0\",\"favicon\":\"\"},{\"id\":\"56\",\"title\":\"Understanding the Opioid Overdose Epidemic - CDC\",\"description\":\"Jun 9, 2025 · Approximately 105,000 people died from drug overdose in 2023 and nearly 80,000 of those deaths involved opioids (about 76%). The number of ...\",\"url\":\"https://www.cdc.gov/overdose-prevention/about/understanding-the-opioid-overdose-epidemic.html\",\"favicon\":\"\"},{\"id\":\"57\",\"title\":\"The temporal relationship between drug supply indicators - NIH\",\"description\":\"We used international drug surveillance databases to assess the relationship between multiple long-term estimates of illegal drug price and purity.Missing:  lags | Show results with:lags\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC3787412/\",\"favicon\":\"\"},{\"id\":\"58\",\"title\":\"China Drug Situation Report 2022\",\"description\":\"Jun 28, 2023 · The results of waste water analysis also showed a significant drop in the consumption of the three main types of drugs: heroin, methamphetamine, ...\",\"url\":\"http://losangeles.china-consulate.gov.cn/eng/topnews/202306/t20230628_11104750.htm\",\"favicon\":\"\"},{\"id\":\"59\",\"title\":\"Opiate addiction in China: current situation and treatments - PubMed\",\"description\":\"Findings: The number of registered addicts in 2004 was 1.14 million (more than 75% of them heroin addicts), but the actual number is probably far higher. Opiate ...Missing:  estimates | Show results with:estimates\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/16669899/\",\"favicon\":\"\"},{\"id\":\"60\",\"title\":\"China expands surveillance of sewage to police illegal drug use\",\"description\":\"Jul 16, 2018 · Dozens of cities across China are applying an unusual forensic technique to monitor illegal drug use: chemically analysing sewage for traces of drugs.\",\"url\":\"https://www.nature.com/articles/d41586-018-05728-3\",\"favicon\":\"\"},{\"id\":\"61\",\"title\":\"The epidemiology of substance use disorders in Saudi Arabia\",\"description\":\"Jan 8, 2025 · Saudi Arabia and other Islamic countries employ strong prohibitions against the consumption and proliferation of alcohol and illicit drugs; ...\",\"url\":\"https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-024-21190-5\",\"favicon\":\"\"},{\"id\":\"62\",\"title\":\"Prescription opioid misuse in relation to addiction susceptibility ... - NIH\",\"description\":\"Aug 25, 2023 · Results from our study suggest a high prevalence of opioid misuse among college women in Saudi Arabia, which may be a product of unmonitored ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC10491761/\",\"favicon\":\"\"},{\"id\":\"63\",\"title\":\"Wastewater-based epidemiology for illicit drugs: A critical review on ...\",\"description\":\"Dec 1, 2021 · Drug consumption can be estimated by measuring human excretion products in untreated wastewater, known as wastewater-based epidemiology (WBE).\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S0043135421009830\",\"favicon\":\"\"},{\"id\":\"64\",\"title\":\"Prevalence of consumption of illicit drugs and associated factors ...\",\"description\":\"Apr 29, 2024 · The study found that the prevalence of lifetime and 12-month illicit drug consumption in the population was 2.3% and 0.7%, respectively. The ...\",\"url\":\"https://annals.edu.sg/prevalence-of-consumption-of-illicit-drugs-and-associated-factors-from-a-nationwide-epidemiological-survey-the-singapore-health-and-lifestyle-survey/\",\"favicon\":\"\"},{\"id\":\"65\",\"title\":\"Opinion | Singapore is winning the war on drugs. Here's how.\",\"description\":\"Mar 11, 2018 · Singapore has one of the lowest rates of drug abuse in the world: 30 opiates abusers per 100,000 people, compared with 600 in the United States.Missing:  prevalence | Show results with:prevalence\",\"url\":\"https://www.washingtonpost.com/opinions/singapore-is-winning-the-war-on-drugs-heres-how/2018/03/11/b8c25278-22e9-11e8-946c-9420060cb7bd_story.html\",\"favicon\":\"\"},{\"id\":\"66\",\"title\":\"[PDF] A Century of International Drug Control - Unodc\",\"description\":\"million opiate users, rather than the 17 million it must care for today. The prevalence rate of opiate use declined in Asia from. 3.3% of the population in ...Missing:  2023 | Show results with:2023\u003c|separator|\u003e\",\"url\":\"https://www.unodc.org/documents/data-and-analysis/Studies/100_Years_of_Drug_Control.pdf\",\"favicon\":\"\"},{\"id\":\"67\",\"title\":\"[PDF] The Impact of Drug Decriminalization in Portugal\",\"description\":\"Indeed, empirical data show lower lifetime prevalence rates in the post-decriminalization period for almost every category of drug and for several age groups.\",\"url\":\"https://ftp.iza.org/dp10895.pdf\",\"favicon\":\"\"},{\"id\":\"68\",\"title\":\"Drug decriminalisation in Portugal: setting the record straight.\",\"description\":\"May 13, 2021 · As of 2015, there were an estimated 33,290 'high risk' opioid users in Portugal.22 Per 100,000 population, this is above the European average.23 ...Missing:  empirical | Show results with:empirical\",\"url\":\"https://transformdrugs.org/blog/drug-decriminalisation-in-portugal-setting-the-record-straight\",\"favicon\":\"\"},{\"id\":\"69\",\"title\":\"[PDF] Drug Decriminalization in Portugal: Challenges and Limitations\",\"description\":\"Portugal's decriminalized drug policy has been cited as proof that softening drug laws does not increase illicit drug use or the consequences of drug use. This ...Missing:  empirical | Show results with:empirical\",\"url\":\"https://obamawhitehouse.archives.gov/sites/default/files/ondcp/Fact_Sheets/portugal_fact_sheet_8-25-10.pdf\",\"favicon\":\"\"}],\"images\":[{\"id\":\"32df344ea2a6\",\"caption\":\"Flag of Iran\",\"url\":\"./_assets_/Flag_of_Iran.svg.png\",\"position\":\"CENTER\",\"width\":0,\"height\":0},{\"id\":\"32df344ea2a6\",\"caption\":\"Flag of Iran\",\"url\":\"./_assets_/Flag_of_Iran.svg.png\",\"position\":\"CENTER\",\"width\":0,\"height\":0},{\"id\":\"89e9efae1a39\",\"caption\":\"Opium production hub\",\"url\":\"./_assets_/Flag_of_the_Taliban.svg.png\",\"position\":\"CENTER\",\"width\":0,\"height\":0}],\"fixedIssues\":[],\"slug\":\"List_of_countries_by_prevalence_of_opiates_use\",\"title\":\"List of countries by prevalence of opiates use\",\"content\":\"$1f\",\"description\":\"List of countries by prevalence of opiates use\\n\\nFlag of Iran\\nThe list of countries by prevalence of opiates use ranks nations based on the estimated annual prevalence rate of opiate...\",\"metadata\":{\"categories\":[],\"lastModified\":\"1761582691\",\"contentLength\":\"44009\",\"version\":\"1.0\",\"lastEditor\":\"system\",\"language\":\"en\",\"isRedirect\":false,\"redirectTarget\":\"\",\"isWithheld\":false},\"stats\":{\"totalViews\":\"69330\",\"recentViews\":\"69330\",\"dailyAvgViews\":2311,\"qualityScore\":1,\"lastViewed\":\"1761885275\"},\"linkedPages\":null},\"found\":true},\"dataUpdateCount\":1,\"dataUpdatedAt\":1761885275652,\"error\":null,\"errorUpdateCount\":0,\"errorUpdatedAt\":0,\"fetchFailureCount\":0,\"fetchFailureReason\":null,\"fetchMeta\":null,\"isInvalidated\":false,\"status\":\"success\",\"fetchStatus\":\"idle\"},\"queryKey\":[\"page\",\"List_of_countries_by_prevalence_of_opiates_use\"],\"queryHash\":\"[\\\"page\\\",\\\"List_of_countries_by_prevalence_of_opiates_use\\\"]\"}]},\"children\":\"$L20\"}]\n"])</script><script nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx">self.__next_f.push([1,"c:{\"metadata\":[[\"$\",\"title\",\"0\",{\"children\":\"List of countries by prevalence of opiates use\"}],[\"$\",\"meta\",\"1\",{\"name\":\"description\",\"content\":\"The list of countries by prevalence of opiates use ranks nations based on the estimated annual prevalence rate of opiate consumption—encompassing substances like heroin, opium, and morphine—among the population aged 15–64, as compiled from national surveys, treatment records, and indirect indicators by the United Nations Office on Drugs and Crime (UNODC). These figures reflect past-year use and serve as a metric for assessing the scale of illicit opiate involvement relative to population size,...\"}],[\"$\",\"meta\",\"2\",{\"name\":\"author\",\"content\":\"system\"}],[\"$\",\"link\",\"3\",{\"rel\":\"manifest\",\"href\":\"/manifest.webmanifest\",\"crossOrigin\":\"$undefined\"}],[\"$\",\"meta\",\"4\",{\"name\":\"robots\",\"content\":\"index, follow\"}],[\"$\",\"meta\",\"5\",{\"name\":\"googlebot\",\"content\":\"index, follow, max-snippet:-1\"}],[\"$\",\"link\",\"6\",{\"rel\":\"canonical\",\"href\":\"https://grokipedia.com/page/List_of_countries_by_prevalence_of_opiates_use\"}],[\"$\",\"meta\",\"7\",{\"property\":\"og:title\",\"content\":\"List of countries by prevalence of opiates use\"}],[\"$\",\"meta\",\"8\",{\"property\":\"og:description\",\"content\":\"The list of countries by prevalence of opiates use ranks nations based on the estimated annual prevalence rate of opiate consumption—encompassing substances like heroin, opium, and morphine—among the population aged 15–64, as compiled from national surveys, treatment records, and indirect indicators by the United Nations Office on Drugs and Crime (UNODC). These figures reflect past-year use and serve as a metric for assessing the scale of illicit opiate involvement relative to population size,...\"}],[\"$\",\"meta\",\"9\",{\"property\":\"og:url\",\"content\":\"https://grokipedia.com/page/List_of_countries_by_prevalence_of_opiates_use\"}],[\"$\",\"meta\",\"10\",{\"property\":\"og:site_name\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",\"11\",{\"property\":\"og:locale\",\"content\":\"en\"}],[\"$\",\"meta\",\"12\",{\"property\":\"og:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"meta\",\"13\",{\"property\":\"og:image:width\",\"content\":\"512\"}],[\"$\",\"meta\",\"14\",{\"property\":\"og:image:height\",\"content\":\"512\"}],[\"$\",\"meta\",\"15\",{\"property\":\"og:image:alt\",\"content\":\"List of countries by prevalence of opiates use\"}],[\"$\",\"meta\",\"16\",{\"property\":\"og:type\",\"content\":\"article\"}],[\"$\",\"meta\",\"17\",{\"property\":\"article:modified_time\",\"content\":\"1970-01-21T09:19:42.691Z\"}],[\"$\",\"meta\",\"18\",{\"name\":\"twitter:card\",\"content\":\"summary\"}],[\"$\",\"meta\",\"19\",{\"name\":\"twitter:creator\",\"content\":\"@Grokipedia\"}],[\"$\",\"meta\",\"20\",{\"name\":\"twitter:title\",\"content\":\"List of countries by prevalence of opiates use\"}],[\"$\",\"meta\",\"21\",{\"name\":\"twitter:description\",\"content\":\"The list of countries by prevalence of opiates use ranks nations based on the estimated annual prevalence rate of opiate consumption—encompassing substances like heroin, opium, and morphine—among the population aged 15–64, as compiled from national surveys, treatment records, and indirect indicators by the United Nations Office on Drugs and Crime (UNODC). These figures reflect past-year use and serve as a metric for assessing the scale of illicit opiate involvement relative to population size,...\"}],[\"$\",\"meta\",\"22\",{\"name\":\"twitter:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"link\",\"23\",{\"rel\":\"icon\",\"href\":\"/favicon.ico\",\"type\":\"image/x-icon\",\"sizes\":\"16x16\"}],[\"$\",\"$L21\",\"24\",{}]],\"error\":null,\"digest\":\"$undefined\"}\n"])</script><script nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx">self.__next_f.push([1,"11:\"$c:metadata\"\n"])</script><script nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx">self.__next_f.push([1,"22:I[61172,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"PageEditorProvider\"]\n"])</script><script nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx">self.__next_f.push([1,"23:I[63493,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"default\"]\n"])</script><script nonce="ZWFlYTc3NjItOGZmYi00ODA0LWI2MzYtMjViYWUyYzI3NGUx">self.__next_f.push([1,"20:[\"$\",\"$L22\",null,{\"children\":[\"$\",\"$L23\",null,{\"slug\":\"List_of_countries_by_prevalence_of_opiates_use\"}]}]\n"])</script></body></html>